CEO.CA SEDI filings for

SEDI Insider filing browser

Date	Issuer	Insider	Transaction	Amount	New Balance ⓘ The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2024-11-18 09:23 Tx date 2024-11-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,654 +355 vol $13.11 each	367,154
Filed 2024-10-16 15:03 Tx date 2024-10-16	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,653 +271 vol $17.17 each	366,799
Filed 2024-09-18 08:34 Tx date 2024-09-16	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,641 +296 vol $15.68 each	366,528
Filed 2024-08-16 10:44 Tx date 2024-08-16	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,648 +332 vol $14.00 each	366,232
Filed 2024-07-16 14:33 Tx date 2024-07-16	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,650 +557 vol $8.35 each	365,900
Filed 2024-06-17 09:37 Tx date 2024-06-17	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,655 +537 vol $8.67 each	365,343
Filed 2024-05-16 15:39 Tx date 2024-05-16	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,656 +518 vol $8.99 each	364,806
Filed 2024-04-15 16:52 Tx date 2024-04-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,658 +527 vol $8.84 each	364,288
Filed 2024-03-28 14:49 Tx date 2024-03-27	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-235,469.806 -25,685 vol $9.17 each	0
Filed 2024-03-28 14:47 Tx date 2024-03-27	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$235,469 +25,685 vol $9.17 each	25,685
Filed 2024-03-25 15:43 Tx date 2024-03-20	$CPH Cipher Pharmaceuticals Inc.	Mailling, Ryan 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$163,000 +20,000 vol $8.15 each	85,000
Filed 2024-03-25 15:41 Tx date 2024-03-20	$CPH Cipher Pharmaceuticals Inc.	Mull, Craig 3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$1,080,486 +132,575 vol $8.15 each	535,809
Filed 2024-03-25 15:34 Tx date 2024-03-20	$CPH Cipher Pharmaceuticals Inc.	Jacobs, Bryan 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$407,500 +50,000 vol $8.15 each	212,109
Filed 2024-03-19 09:53 Tx date 2024-03-18	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,660 +606 vol $7.69 each	363,761
Filed 2024-02-20 09:58 Tx date 2024-02-16	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,655 +667 vol $6.98 each	363,155
Filed 2024-01-18 12:21 Tx date 2024-01-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,658 +795 vol $5.86 each	362,488
Filed 2024-01-02 11:54 Tx date 2023-12-29	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-374,161.5072 -60,372 vol $6.20 each	0
Filed 2024-01-02 11:52 Tx date 2023-12-29	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$374,161 +60,372 vol $6.20 each	60,372
Filed 2023-12-20 12:55 Tx date 2023-12-18	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,591 +713 vol $6.44 each	361,693
Filed 2023-12-01 15:20 Tx date 2023-11-30	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-180,983.4386 -29,819 vol $6.07 each	0
Filed 2023-12-01 15:19 Tx date 2023-11-30	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$180,983 +29,819 vol $6.07 each	29,819
Filed 2023-11-17 14:15 Tx date 2023-11-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,626 +883 vol $5.24 each	360,980
Filed 2023-10-13 15:46 Tx date 2023-10-12	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-5,999,992.65 -1,290,321 vol $4.65 each	0
Filed 2023-10-13 15:44 Tx date 2023-10-12	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$5,999,992 +1,290,321 vol $4.65 each	1,290,321
Filed 2023-09-22 16:10 Tx date 2023-09-18	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,617 +1,026 vol $4.50 each	359,015
Filed 2023-09-05 10:08 Tx date 2023-08-31	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-180,439.6272 -48,848 vol $3.69 each	0
Filed 2023-09-05 10:06 Tx date 2023-08-31	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$180,439 +48,848 vol $3.69 each	48,848
Filed 2023-08-17 12:54 Tx date 2023-08-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,615 +1,330 vol $3.47 each	357,989
Filed 2023-07-18 13:30 Tx date 2023-07-14	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,635 +1,332 vol $3.48 each	356,659
Filed 2023-07-04 12:03 Tx date 2023-06-29	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-235,979.757 -62,379 vol $3.78 each	0
Filed 2023-07-04 12:01 Tx date 2023-06-29	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$235,979 +62,379 vol $3.78 each	62,379
Filed 2023-06-30 15:07 Tx date 2023-06-21	$CPH Cipher Pharmaceuticals Inc.	Walinski, Hubert 4 - Director of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+2,500 vol	2,500
Filed 2023-06-30 15:06 Tx date 2023-06-21	$CPH Cipher Pharmaceuticals Inc.	Walinski, Hubert 4 - Director of Issuer Direct Ownership	Restricted Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2023-06-30 15:04 Tx date 2023-06-22	$CPH Cipher Pharmaceuticals Inc.	Walinski, Hubert 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$73,800 +20,000 vol $3.69 each	25,000
Filed 2023-06-30 15:03 Tx date 2023-06-21	$CPH Cipher Pharmaceuticals Inc.	Walinski, Hubert 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$18,450 +5,000 vol $3.69 each	5,000
Filed 2023-06-30 15:02 Tx date 2023-06-21	$CPH Cipher Pharmaceuticals Inc.	Walinski, Hubert 4 - Director of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2023-06-30 14:41 Tx date 2023-06-21	$CPH Cipher Pharmaceuticals Inc.	Deeth, Douglas Norman 4 - Director of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+2,500 vol	2,500
Filed 2023-06-30 14:38 Tx date 2023-06-21	$CPH Cipher Pharmaceuticals Inc.	Deeth, Douglas Norman 4 - Director of Issuer Direct Ownership	Restricted Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2023-06-30 14:37 Tx date 2023-06-22	$CPH Cipher Pharmaceuticals Inc.	Deeth, Douglas Norman 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$73,800 +20,000 vol $3.69 each	25,000
Filed 2023-06-30 14:35 Tx date 2023-06-21	$CPH Cipher Pharmaceuticals Inc.	Deeth, Douglas Norman 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$18,450 +5,000 vol $3.69 each	5,000
Filed 2023-06-30 14:26 Tx date 2023-06-21	$CPH Cipher Pharmaceuticals Inc.	Deeth, Douglas Norman 4 - Director of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2023-06-26 16:59 Tx date 2023-06-21	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+7,500 vol	12,876
Filed 2023-06-26 16:59 Tx date 2023-06-21	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+7,500 vol	12,876
Filed 2023-06-26 16:57 Tx date 2023-06-21	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$18,450 +5,000 vol $3.69 each	42,521
Filed 2023-06-26 16:57 Tx date 2023-06-21	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$18,450 +5,000 vol $3.69 each	42,521
Filed 2023-06-26 16:54 Tx date 2023-06-21	$CPH Cipher Pharmaceuticals Inc.	Mull, Craig 3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+2,500 vol	296,831
Filed 2023-06-26 16:54 Tx date 2023-06-21	$CPH Cipher Pharmaceuticals Inc.	Mull, Craig 3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+2,500 vol	296,831
Filed 2023-06-26 16:47 Tx date 2023-06-21	$CPH Cipher Pharmaceuticals Inc.	Mull, Craig 3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$18,450 +5,000 vol $3.69 each	403,234
Filed 2023-06-26 16:47 Tx date 2023-06-21	$CPH Cipher Pharmaceuticals Inc.	Mull, Craig 3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$18,450 +5,000 vol $3.69 each	403,234
Filed 2023-06-16 09:59 Tx date 2023-06-14	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,586 +1,207 vol $3.80 each	355,327
Filed 2023-06-06 10:50 Tx date 2023-05-31	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-98,498.841 -26,817 vol $3.67 each	0
Filed 2023-06-06 10:48 Tx date 2023-05-31	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$98,498 +26,817 vol $3.67 each	26,817
Filed 2023-05-17 11:45 Tx date 2023-04-24	$CPH Cipher Pharmaceuticals Inc.	Mailling, Ryan 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$219,050 +65,000 vol $3.37 each	65,000
Filed 2023-05-17 11:37 Tx date 2023-04-24	$CPH Cipher Pharmaceuticals Inc.	Mailling, Ryan 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2023-05-15 13:17 Tx date 2023-05-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$5,263 +1,562 vol $3.37 each	354,120
Filed 2023-04-22 21:37 Tx date 2023-04-18	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,012 +1,180 vol $3.40 each	352,558
Filed 2023-04-10 10:03 Tx date 2023-03-31	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	-28,986 vol	0
Filed 2023-04-10 09:40 Tx date 2023-03-31	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$97,349 +28,986 vol $3.36 each	28,986
Filed 2023-04-09 19:40 Tx date 2023-04-03	$CPH Cipher Pharmaceuticals Inc.	Mull, Craig 3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-122,049 vol	294,331
Filed 2023-04-09 19:39 Tx date 2023-04-03	$CPH Cipher Pharmaceuticals Inc.	Mull, Craig 3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$440,596 +122,049 vol $3.61 each	719,135
Filed 2023-04-09 19:28 Tx date 2023-03-29	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-7,500 vol	5,376
Filed 2023-04-09 19:12 Tx date 2023-03-29	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	-7,500 vol
Filed 2023-04-09 19:08 Tx date 2023-03-29	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$28,125 +7,500 vol $3.75 each	351,378
Filed 2023-04-09 19:02 Tx date 2021-03-18	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+7,500 vol	14,376
Filed 2023-04-09 11:53 Tx date 2023-03-29	$CPH Cipher Pharmaceuticals Inc.	Steiner, Cathy Robin 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-2,500 vol	0
Filed 2023-04-09 11:50 Tx date 2023-03-29	$CPH Cipher Pharmaceuticals Inc.	Steiner, Cathy Robin 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$9,375 +2,500 vol $3.75 each	5,000
Filed 2023-04-09 11:43 Tx date 2023-03-29	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-2,500 vol	0
Filed 2023-04-09 11:40 Tx date 2023-03-29	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$9,375 +2,500 vol $3.75 each	91,710
Filed 2023-04-09 11:36 Tx date 2021-03-18	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+2,500 vol	4,000
Filed 2023-04-09 11:19 Tx date 2023-03-29	$CPH Cipher Pharmaceuticals Inc.	Gajewczyk, Diane 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-24,602 vol	41,705
Filed 2023-04-09 11:17 Tx date 2023-03-29	$CPH Cipher Pharmaceuticals Inc.	Gajewczyk, Diane 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,552 vol	66,307
Filed 2023-04-09 11:16 Tx date 2023-03-29	$CPH Cipher Pharmaceuticals Inc.	Gajewczyk, Diane 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-6,065 vol	67,859
Filed 2023-04-09 11:13 Tx date 2023-03-29	$CPH Cipher Pharmaceuticals Inc.	Gajewczyk, Diane 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$90,289 +24,602 vol $3.67 each	84,036
Filed 2023-04-09 11:11 Tx date 2023-03-29	$CPH Cipher Pharmaceuticals Inc.	Gajewczyk, Diane 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$5,773 +1,552 vol $3.72 each	59,434
Filed 2023-04-09 11:10 Tx date 2023-03-29	$CPH Cipher Pharmaceuticals Inc.	Gajewczyk, Diane 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$22,743 +6,065 vol $3.75 each	57,882
Filed 2023-04-09 10:52 Tx date 2023-03-29	$CPH Cipher Pharmaceuticals Inc.	Deboeck, Arthur Marie Joseph Ghislain 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-2,500 vol	0
Filed 2023-04-09 10:38 Tx date 2021-03-18	$CPH Cipher Pharmaceuticals Inc.	Deboeck, Arthur Marie Joseph Ghislain 4 - Director of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+2,500 vol	4,000
Filed 2023-03-30 11:34 Tx date 2023-03-29	$CPH Cipher Pharmaceuticals Inc.	Deboeck, Arthur Marie Joseph Ghislain 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$9,375 +2,500 vol $3.75 each	251,540
Filed 2023-03-30 11:28 Tx date 2023-03-29	$CPH Cipher Pharmaceuticals Inc.	Mull, Craig 3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$51,791 +14,112 vol $3.67 each	597,086
Filed 2023-03-30 11:26 Tx date 2023-03-29	$CPH Cipher Pharmaceuticals Inc.	Mull, Craig 3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$209,583 +55,889 vol $3.75 each	582,974
Filed 2023-03-30 11:24 Tx date 2023-03-29	$CPH Cipher Pharmaceuticals Inc.	Mull, Craig 3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-14,112 vol	416,380
Filed 2023-03-30 11:22 Tx date 2023-03-29	$CPH Cipher Pharmaceuticals Inc.	Mull, Craig 3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-55,889 vol	430,492
Filed 2023-03-30 11:18 Tx date 2023-03-29	$CPH Cipher Pharmaceuticals Inc.	Mull, Craig 3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$51,791 +14,112 vol $3.67 each	527,085
Filed 2023-03-30 11:16 Tx date 2023-03-29	$CPH Cipher Pharmaceuticals Inc.	Mull, Craig 3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$209,583 +55,889 vol $3.75 each	512,973
Filed 2023-03-23 19:04 Tx date 2023-03-16	$CPH Cipher Pharmaceuticals Inc.	Mull, Craig 3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+244,098 vol	486,381
Filed 2023-03-23 18:50 Tx date 2023-03-16	$CPH Cipher Pharmaceuticals Inc.	Mull, Craig 3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$662,966 +176,791 vol $3.75 each	398,234
Filed 2023-03-23 17:45 Tx date 2023-03-16	$CPH Cipher Pharmaceuticals Inc.	Jacobs, Bryan 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+16,719 vol	16,719
Filed 2023-03-23 17:39 Tx date 2022-08-15	$CPH Cipher Pharmaceuticals Inc.	Jacobs, Bryan 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2023-03-23 17:11 Tx date 2023-03-16	$CPH Cipher Pharmaceuticals Inc.	Gajewczyk, Diane 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+3,928 vol	73,924
Filed 2023-03-23 16:11 Tx date 2023-03-16	$CPH Cipher Pharmaceuticals Inc.	Jacobs, Bryan 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$45,408 +12,109 vol $3.75 each	162,109
Filed 2023-03-23 15:19 Tx date 2023-03-16	$CPH Cipher Pharmaceuticals Inc.	Gajewczyk, Diane 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$10,668 +2,845 vol $3.75 each	197,934
Filed 2023-03-21 14:49 Tx date 2023-03-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,620 +1,216 vol $3.80 each	343,878
Filed 2023-03-16 08:24 Tx date 2022-06-30	$CPH Cipher Pharmaceuticals Inc.	Mull, Craig 3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer Holder: 1207407 Ontario Limited (Indirect Ownership)	Common Shares 97 - Other	+9,566,150 vol	9,566,150
Filed 2023-03-16 08:22 Tx date 2019-03-26	$CPH Cipher Pharmaceuticals Inc.	Mull, Craig 3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer Holder: 1207407 Ontario Limited (Indirect Ownership)	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2023-03-16 08:19 Tx date 2022-06-30	$CPH Cipher Pharmaceuticals Inc.	Mull, John 3 - 10% Security Holder of Issuer Holder: 1207407 Ontario Limited (Indirect Ownership)	Common Shares 97 - Other	-9,436,150 vol	0
Filed 2023-02-21 13:56 Tx date 2023-02-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,617 +1,279 vol $3.61 each	342,662
Filed 2023-01-18 15:38 Tx date 2023-01-16	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,636 +1,243 vol $3.73 each	341,383
Filed 2023-01-10 13:38 Tx date 2022-12-30	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	-45,610 vol	0
Filed 2023-01-10 13:38 Tx date 2022-12-30	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$171,037 +45,610 vol $3.75 each	45,610
Filed 2022-12-20 10:32 Tx date 2022-12-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,309 +1,105 vol $3.90 each	340,140
Filed 2022-12-20 10:29 Tx date 2022-12-14	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-12,950 -3,500 vol $3.70 each	89,210
Filed 2022-12-20 10:26 Tx date 2022-12-14	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$12,355 +3,500 vol $3.53 each	92,710
Filed 2022-12-20 10:24 Tx date 2022-12-14	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-12,355 -3,500 vol $3.53 each	34,021
Filed 2022-12-19 11:39 Tx date 2022-12-12	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-23,760 -6,000 vol $3.96 each	89,210
Filed 2022-12-12 15:05 Tx date 2022-12-09	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-15,800 -4,000 vol $3.95 each	95,210
Filed 2022-12-12 15:04 Tx date 2022-12-09	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-15,600 -4,000 vol $3.90 each	99,210
Filed 2022-12-12 15:04 Tx date 2022-12-08	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-11,580 -3,000 vol $3.86 each	103,210
Filed 2022-12-12 15:03 Tx date 2022-12-07	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-18,500 -5,000 vol $3.70 each	106,210
Filed 2022-12-12 14:25 Tx date 2022-11-30	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	-32,886 vol	0
Filed 2022-12-12 14:25 Tx date 2022-11-30	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$113,127 +32,886 vol $3.44 each	32,886
Filed 2022-11-17 10:56 Tx date 2022-11-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,318 +1,259 vol $3.43 each	339,035
Filed 2022-11-16 14:25 Tx date 2022-11-14	$CPH Cipher Pharmaceuticals Inc.	Jacobs, Bryan 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$16,500 +5,000 vol $3.30 each	5,000
Filed 2022-11-16 14:24 Tx date 2022-08-15	$CPH Cipher Pharmaceuticals Inc.	Jacobs, Bryan 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2022-10-26 12:15 Tx date 2022-10-24	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,277 +1,407 vol $3.04 each	337,776
Filed 2022-10-11 10:35 Tx date 2022-09-30	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	-39,317 vol	0
Filed 2022-10-11 10:34 Tx date 2022-09-30	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$127,387 +39,317 vol $3.24 each	39,317
Filed 2022-09-19 11:44 Tx date 2022-09-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,569 +1,523 vol $3.00 each	336,369
Filed 2022-09-19 11:42 Tx date 2022-09-15	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,077 +359 vol $3.00 each	111,210
Filed 2022-09-06 12:42 Tx date 2022-08-15	$CPH Cipher Pharmaceuticals Inc.	Jacobs, Bryan 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$346,500 +150,000 vol $2.31 each	150,000
Filed 2022-09-06 12:36 Tx date 2022-08-15	$CPH Cipher Pharmaceuticals Inc.	Jacobs, Bryan 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2022-08-22 11:20 Tx date 2022-08-16	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,584 +2,002 vol $2.29 each	334,846
Filed 2022-08-22 11:18 Tx date 2022-08-16	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,080 +472 vol $2.29 each	110,851
Filed 2022-08-10 15:09 Tx date 2022-07-31	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	-110,545 vol	0
Filed 2022-08-10 15:09 Tx date 2022-07-31	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$244,304 +110,545 vol $2.21 each	110,545
Filed 2022-07-18 12:53 Tx date 2022-07-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,020 +1,836 vol $2.19 each	332,844
Filed 2022-07-18 12:51 Tx date 2022-07-15	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,079 +493 vol $2.19 each	110,379
Filed 2022-07-12 14:51 Tx date 2022-06-30	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	-123,000 vol	0
Filed 2022-07-12 14:51 Tx date 2022-06-30	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$290,280 +123,000 vol $2.36 each	123,000
Filed 2022-06-21 09:51 Tx date 2022-06-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,032 +1,716 vol $2.35 each	331,008
Filed 2022-06-21 09:48 Tx date 2022-06-15	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,083 +461 vol $2.35 each	109,886
Filed 2022-06-10 11:52 Tx date 2022-05-31	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	-140,900 vol	0
Filed 2022-06-10 11:52 Tx date 2022-05-31	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$332,524 +140,900 vol $2.36 each	140,900
Filed 2022-05-26 11:29 Tx date 2022-05-20	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$917.39 +461 vol $1.99 each	109,425
Filed 2022-05-26 11:27 Tx date 2022-05-20	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,414 +1,716 vol $1.99 each	329,292
Filed 2022-05-10 12:02 Tx date 2022-04-30	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	-137,400 vol	0
Filed 2022-05-10 12:01 Tx date 2022-04-30	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$331,134 +137,400 vol $2.41 each	137,400
Filed 2022-04-26 14:19 Tx date 2022-04-20	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$917.51 +439 vol $2.09 each	108,964
Filed 2022-04-26 14:16 Tx date 2022-04-20	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,415 +1,634 vol $2.09 each	327,576
Filed 2022-04-11 20:12 Tx date 2022-03-31	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	-196,300 vol	0
Filed 2022-04-11 20:12 Tx date 2022-03-31	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$429,897 +196,300 vol $2.19 each	196,300
Filed 2022-04-04 19:19 Tx date 2022-04-01	$CPH Cipher Pharmaceuticals Inc.	Gajewczyk, Diane 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,552 vol	69,996
Filed 2022-04-04 19:19 Tx date 2022-04-01	$CPH Cipher Pharmaceuticals Inc.	Gajewczyk, Diane 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-24,603 vol	71,548
Filed 2022-04-04 19:18 Tx date 2022-04-01	$CPH Cipher Pharmaceuticals Inc.	Gajewczyk, Diane 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$3,243 +1,552 vol $2.09 each	51,817
Filed 2022-04-04 19:17 Tx date 2022-04-01	$CPH Cipher Pharmaceuticals Inc.	Gajewczyk, Diane 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$55,356 +24,603 vol $2.25 each	50,265
Filed 2022-04-04 19:15 Tx date 2022-04-01	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-7,500 vol	5,376
Filed 2022-04-04 19:14 Tx date 2022-04-01	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$15,674 +7,500 vol $2.09 each	325,942
Filed 2022-04-04 19:13 Tx date 2022-04-01	$CPH Cipher Pharmaceuticals Inc.	Steiner, Cathy Robin 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-2,500 vol	2,500
Filed 2022-04-04 19:12 Tx date 2022-04-01	$CPH Cipher Pharmaceuticals Inc.	Steiner, Cathy Robin 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$5,225 +2,500 vol $2.09 each	2,500
Filed 2022-04-04 19:12 Tx date 2020-10-08	$CPH Cipher Pharmaceuticals Inc.	Steiner, Cathy Robin 4 - Director of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2022-04-04 19:10 Tx date 2022-04-01	$CPH Cipher Pharmaceuticals Inc.	Mull, Craig 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-2,500 vol	242,283
Filed 2022-04-04 19:09 Tx date 2022-04-01	$CPH Cipher Pharmaceuticals Inc.	Mull, Craig 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-14,112 vol	244,783
Filed 2022-04-04 19:08 Tx date 2022-04-01	$CPH Cipher Pharmaceuticals Inc.	Mull, Craig 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$31,752 +14,112 vol $2.25 each	457,084
Filed 2022-04-04 19:08 Tx date 2022-04-01	$CPH Cipher Pharmaceuticals Inc.	Mull, Craig 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$5,225 +2,500 vol $2.09 each	442,972
Filed 2022-04-04 19:05 Tx date 2022-04-01	$CPH Cipher Pharmaceuticals Inc.	Deboeck, Arthur Marie Joseph Ghislain 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-2,500 vol	0
Filed 2022-04-04 19:05 Tx date 2022-04-01	$CPH Cipher Pharmaceuticals Inc.	Deboeck, Arthur Marie Joseph Ghislain 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$5,225 +2,500 vol $2.09 each	249,040
Filed 2022-04-04 19:03 Tx date 2022-04-01	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-2,500 vol	0
Filed 2022-04-04 19:02 Tx date 2022-04-01	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$5,225 +2,500 vol $2.09 each	108,525
Filed 2022-04-04 18:57 Tx date 2022-04-01	$CPH Cipher Pharmaceuticals Inc.	Mull, John 3 - 10% Security Holder of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-2,500 vol	5,000
Filed 2022-04-04 18:55 Tx date 2022-04-01	$CPH Cipher Pharmaceuticals Inc.	Mull, John 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$5,225 +2,500 vol $2.09 each	490,355
Filed 2022-03-30 14:46 Tx date 2022-03-17	$CPH Cipher Pharmaceuticals Inc.	Langille, Scott 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+18,546 vol	18,546
Filed 2022-03-30 14:45 Tx date 2020-07-03	$CPH Cipher Pharmaceuticals Inc.	Langille, Scott 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2022-03-30 14:44 Tx date 2022-03-17	$CPH Cipher Pharmaceuticals Inc.	Langille, Scott 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$5,952 +2,743 vol $2.17 each	52,743
Filed 2022-03-30 14:40 Tx date 2022-03-17	$CPH Cipher Pharmaceuticals Inc.	Gajewczyk, Diane 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+24,260 vol	96,151
Filed 2022-03-30 14:39 Tx date 2022-03-17	$CPH Cipher Pharmaceuticals Inc.	Gajewczyk, Diane 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$103,452 +47,674 vol $2.17 each	195,089
Filed 2022-03-30 14:37 Tx date 2022-03-17	$CPH Cipher Pharmaceuticals Inc.	Steiner, Cathy Robin 4 - Director of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+2,500 vol	5,000
Filed 2022-03-30 14:36 Tx date 2022-03-17	$CPH Cipher Pharmaceuticals Inc.	Steiner, Cathy Robin 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$10,850 +5,000 vol $2.17 each	30,000
Filed 2022-03-30 14:33 Tx date 2022-03-17	$CPH Cipher Pharmaceuticals Inc.	Mull, Craig 4 - Director of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+216,059 vol	258,895
Filed 2022-03-30 14:31 Tx date 2022-03-17	$CPH Cipher Pharmaceuticals Inc.	Mull, Craig 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$341,866 +157,542 vol $2.17 each	221,443
Filed 2022-03-30 14:28 Tx date 2022-03-17	$CPH Cipher Pharmaceuticals Inc.	Deboeck, Arthur Marie Joseph Ghislain 4 - Director of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+2,500 vol	2,500
Filed 2022-03-30 14:27 Tx date 2022-03-17	$CPH Cipher Pharmaceuticals Inc.	Deboeck, Arthur Marie Joseph Ghislain 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$10,850 +5,000 vol $2.17 each	34,021
Filed 2022-03-30 14:25 Tx date 2022-03-17	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+7,500 vol	12,876
Filed 2022-03-30 14:24 Tx date 2022-03-17	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$10,850 +5,000 vol $2.17 each	37,521
Filed 2022-03-30 14:21 Tx date 2022-03-17	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+2,500 vol	2,500
Filed 2022-03-30 14:20 Tx date 2022-03-17	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$10,850 +5,000 vol $2.17 each	37,521
Filed 2022-03-30 14:17 Tx date 2022-03-17	$CPH Cipher Pharmaceuticals Inc.	Mull, John 3 - 10% Security Holder of Issuer Direct Ownership	Restricted Share Units 50 - Grant of options	$10,850 +5,000 vol $2.17 each	7,500
Filed 2022-03-30 14:10 Tx date 2022-03-17	$CPH Cipher Pharmaceuticals Inc.	Mull, John 3 - 10% Security Holder of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+2,500 vol	2,500
Filed 2022-03-21 13:34 Tx date 2022-03-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,415 +2,070 vol $1.65 each	318,442
Filed 2022-03-11 12:34 Tx date 2022-02-28	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	-136,500 vol	0
Filed 2022-03-11 12:33 Tx date 2022-02-28	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$282,555 +136,500 vol $2.07 each	136,500
Filed 2022-02-20 12:54 Tx date 2022-02-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,415 +1,908 vol $1.79 each	316,372
Filed 2022-02-11 15:07 Tx date 2022-01-31	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	-130,300 vol	0
Filed 2022-02-11 15:06 Tx date 2022-01-31	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$233,237 +130,300 vol $1.79 each	130,300
Filed 2022-01-20 17:00 Tx date 2022-01-17	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$9,115 +5,121 vol $1.78 each	314,464
Filed 2022-01-10 14:36 Tx date 2021-12-31	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	-156,200 vol	0
Filed 2022-01-10 14:22 Tx date 2021-12-31	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$279,598 +156,200 vol $1.79 each	156,200
Filed 2021-12-14 14:18 Tx date 2021-11-30	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	-161,200 vol	0
Filed 2021-12-14 14:16 Tx date 2021-11-30	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$375,596 +161,200 vol $2.33 each	161,200
Filed 2021-11-18 10:01 Tx date 2021-11-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,563 +1,967 vol $2.32 each	309,343
Filed 2021-11-10 14:08 Tx date 2021-10-31	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	-132,800 vol	0
Filed 2021-11-10 14:07 Tx date 2021-10-31	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$333,328 +132,800 vol $2.51 each	132,800
Filed 2021-10-20 11:54 Tx date 2021-10-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,551 +1,828 vol $2.49 each	307,376
Filed 2021-10-13 10:40 Tx date 2021-09-30	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	-116,300 vol	0
Filed 2021-10-13 10:38 Tx date 2021-09-30	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$286,098 +116,300 vol $2.46 each	116,300
Filed 2021-09-20 16:46 Tx date 2021-09-20	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,552 +1,881 vol $2.42 each	305,548
Filed 2021-09-13 12:40 Tx date 2021-08-31	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	-40,500 vol	0
Filed 2021-09-13 12:38 Tx date 2021-08-31	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$58,684 +36,450 vol $1.61 each	40,500
Filed 2021-09-13 12:36 Tx date 2021-08-31	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$6,520 +4,050 vol $1.61 each	4,050
Filed 2021-08-20 11:15 Tx date 2021-08-20	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,570 +2,320 vol $1.97 each	303,667
Filed 2021-08-13 09:55 Tx date 2021-07-30	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-121,317 -76,300 vol $1.59 each	0
Filed 2021-08-13 09:53 Tx date 2021-07-30	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$121,317 +76,300 vol $1.59 each	76,300
Filed 2021-07-27 12:43 Tx date 2021-07-20	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,548 +2,808 vol $1.62 each	301,347
Filed 2021-07-27 12:41 Tx date 2021-07-20	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,056 +652 vol $1.62 each	106,025
Filed 2021-07-13 10:54 Tx date 2021-06-30	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	-145,900 vol	0
Filed 2021-07-13 10:53 Tx date 2021-06-30	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$230,522 +145,900 vol $1.58 each	145,900
Filed 2021-06-22 12:38 Tx date 2021-06-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,875 +2,768 vol $1.40 each	298,539
Filed 2021-06-21 11:56 Tx date 2021-06-15	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$900.20 +643 vol $1.40 each	105,373
Filed 2021-06-11 11:39 Tx date 2021-05-31	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	-102,000 vol	0
Filed 2021-06-11 11:37 Tx date 2021-05-31	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$141,780 +102,000 vol $1.39 each	102,000
Filed 2021-06-04 11:52 Tx date 2021-03-21	$CPH Cipher Pharmaceuticals Inc.	Gajewczyk, Diane 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-24,603 vol	71,891
Filed 2021-06-04 11:48 Tx date 2021-03-21	$CPH Cipher Pharmaceuticals Inc.	Mull, Craig 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-15,613 vol	42,836
Filed 2021-06-04 10:43 Tx date 2021-03-21	$CPH Cipher Pharmaceuticals Inc.	Mull, John 3 - 10% Security Holder of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,500 vol	0
Filed 2021-06-04 10:39 Tx date 2021-03-21	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,500 vol	5,376
Filed 2021-06-04 10:36 Tx date 2021-03-21	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,500 vol	0
Filed 2021-06-04 10:34 Tx date 2021-03-21	$CPH Cipher Pharmaceuticals Inc.	Deboeck, Arthur Marie Joseph Ghislain 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,500 vol	0
Filed 2021-05-28 14:40 Tx date 2021-05-28	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,578 +3,202 vol $1.43 each	295,771
Filed 2021-05-28 14:38 Tx date 2021-05-28	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,063 +744 vol $1.43 each	104,730
Filed 2021-05-26 10:23 Tx date 2021-03-21	$CPH Cipher Pharmaceuticals Inc.	Gajewczyk, Diane 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$25,833 +24,603 vol $1.05 each	25,662
Filed 2021-05-26 10:21 Tx date 2021-03-21	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$1,575 +1,500 vol $1.05 each	289,199
Filed 2021-05-26 10:19 Tx date 2021-03-21	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$1,575 +1,500 vol $1.05 each	80,204
Filed 2021-05-26 10:17 Tx date 2021-03-21	$CPH Cipher Pharmaceuticals Inc.	Deboeck, Arthur Marie Joseph Ghislain 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$1,575 +1,500 vol $1.05 each	246,540
Filed 2021-05-26 09:41 Tx date 2021-03-21	$CPH Cipher Pharmaceuticals Inc.	Mull, Craig 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$16,393 +15,613 vol $1.05 each	440,472
Filed 2021-05-26 09:37 Tx date 2021-03-21	$CPH Cipher Pharmaceuticals Inc.	Mull, John 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$1,575 +1,500 vol $1.05 each	487,855
Filed 2021-05-11 10:27 Tx date 2021-04-30	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	-129,400 vol	0
Filed 2021-05-11 10:25 Tx date 2021-04-30	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$173,396 +129,400 vol $1.34 each	129,400
Filed 2021-04-26 17:51 Tx date 2021-03-18	$CPH Cipher Pharmaceuticals Inc.	Steiner, Cathy Robin 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$4,500 +5,000 vol $0.90 each	25,000
Filed 2021-04-23 10:25 Tx date 2021-04-16	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,549 +3,370 vol $1.35 each	291,069
Filed 2021-04-23 10:22 Tx date 2021-04-16	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,055 +782 vol $1.35 each	102,486
Filed 2021-04-15 17:32 Tx date 2021-03-18	$CPH Cipher Pharmaceuticals Inc.	Steiner, Cathy Robin 4 - Director of Issuer Direct Ownership	Restricted Share Units 50 - Grant of options	+2,500 vol	2,500
Filed 2021-04-15 17:27 Tx date 2020-10-08	$CPH Cipher Pharmaceuticals Inc.	Steiner, Cathy Robin 4 - Director of Issuer Direct Ownership	Restricted Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2021-04-01 19:43 Tx date 2021-03-18	$CPH Cipher Pharmaceuticals Inc.	Steiner, Cathy Robin 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$1,125 +1,250 vol $0.90 each
Filed 2021-04-13 17:05 Tx date 2021-03-31	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	-18,200 vol	0
Filed 2021-04-13 17:04 Tx date 2021-03-31	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$23,660 +18,200 vol $1.30 each	18,200
Filed 2021-04-01 19:43 Tx date 2021-03-18	$CPH Cipher Pharmaceuticals Inc.	Steiner, Cathy Robin 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$1,125 +1,250 vol $0.90 each	21,250
Filed 2021-03-26 14:41 Tx date 2021-03-26	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$4,720 +4,000 vol $1.18 each	101,704
Filed 2021-03-26 09:54 Tx date 2021-03-23	$CPH Cipher Pharmaceuticals Inc.	Langille, Scott 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$31,250 +25,000 vol $1.25 each	25,000
Filed 2021-03-26 09:52 Tx date 2020-07-03	$CPH Cipher Pharmaceuticals Inc.	Langille, Scott 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2021-03-25 13:41 Tx date 2021-03-25	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$7,770 +7,000 vol $1.11 each	97,704
Filed 2021-03-25 13:40 Tx date 2021-03-23	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$14,880 +12,000 vol $1.24 each	90,704
Filed 2021-03-16 12:51 Tx date 2021-03-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,589 +5,099 vol $0.90 each	287,699
Filed 2021-03-16 12:48 Tx date 2021-03-15	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,065 +1,184 vol $0.90 each	78,704
Filed 2021-03-05 14:13 Tx date 2021-01-04	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	-132,000 vol	0
Filed 2021-03-05 14:13 Tx date 2020-12-29	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$115,090 +132,000 vol $0.87 each	132,000
Filed 2021-03-05 12:05 Tx date 2020-11-27	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	-73,500 vol	0
Filed 2021-03-05 12:04 Tx date 2020-11-26	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$68,840 +73,500 vol $0.94 each	73,500
Filed 2021-03-05 11:55 Tx date 2020-09-29	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	-30,000 vol	0
Filed 2021-03-05 11:54 Tx date 2020-09-28	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$34,038 +30,000 vol $1.13 each	30,000
Filed 2021-03-05 11:51 Tx date 2004-01-09	$CPH Cipher Pharmaceuticals Inc.	Cipher Pharmaceuticals Inc. 1 - Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2021-02-22 11:03 Tx date 2021-02-16	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,875 +4,726 vol $0.82 each	282,600
Filed 2021-02-22 11:00 Tx date 2021-02-16	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$899.54 +1,097 vol $0.82 each	77,520
Filed 2021-01-25 10:51 Tx date 2021-01-18	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,576 +4,123 vol $1.11 each	277,874
Filed 2021-01-25 10:48 Tx date 2021-01-18	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,062 +957 vol $1.11 each	76,423
Filed 2020-12-17 15:10 Tx date 2020-12-16	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,927 +5,455 vol $0.72 each	273,751
Filed 2020-12-17 15:07 Tx date 2020-12-16	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$888.48 +1,234 vol $0.72 each	75,466
Filed 2020-12-01 15:18 Tx date 2020-12-01	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$3,480 +4,000 vol $0.87 each	74,232
Filed 2020-11-19 11:40 Tx date 2020-11-12	$CPH Cipher Pharmaceuticals Inc.	Steiner, Cathy Robin 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$18,600 +20,000 vol $0.93 each	20,000
Filed 2020-11-19 11:36 Tx date 2020-10-08	$CPH Cipher Pharmaceuticals Inc.	Steiner, Cathy Robin 4 - Director of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2020-11-19 09:31 Tx date 2020-11-12	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	$4,999 +5,376 vol $0.93 each	6,876
Filed 2020-11-17 10:20 Tx date 2020-11-17	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,936 +4,860 vol $0.81 each	268,296
Filed 2020-11-17 10:16 Tx date 2020-11-17	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$888.57 +1,097 vol $0.81 each	70,232
Filed 2020-11-11 22:47 Tx date 2020-10-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,151 +3,426 vol $0.92 each	263,436
Filed 2020-11-11 22:45 Tx date 2020-10-15	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$860.20 +935 vol $0.92 each	69,135
Filed 2020-09-18 14:48 Tx date 2020-09-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,881 +3,961 vol $0.98 each	260,010
Filed 2020-09-18 14:44 Tx date 2020-09-15	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$901.60 +920 vol $0.98 each	68,200
Filed 2020-09-08 13:46 Tx date 2020-05-26	$CPH Cipher Pharmaceuticals Inc.	Mull, Craig 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+829 vol	424,859
Filed 2020-05-29 16:53 Tx date 2020-05-26	$CPH Cipher Pharmaceuticals Inc.	Mull, Craig 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+806 vol
Filed 2020-08-19 10:50 Tx date 2020-08-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$7,552 +6,625 vol $1.14 each	256,049
Filed 2020-08-19 10:42 Tx date 2020-08-15	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,790 +1,571 vol $1.14 each	67,280
Filed 2020-08-17 15:15 Tx date 2020-08-12	$CPH Cipher Pharmaceuticals Inc.	Langille, Scott 5 - Senior Officer of Issuer Direct Ownership	Options 56 - Grant of rights	$250.00 +25,000 vol $0.01 each	50,000
Filed 2020-08-17 14:44 Tx date 2020-08-12	$CPH Cipher Pharmaceuticals Inc.	Langille, Scott 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$35,750 +25,000 vol $1.43 each	25,000
Filed 2020-08-17 14:36 Tx date 2020-07-03	$CPH Cipher Pharmaceuticals Inc.	Langille, Scott 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2020-06-25 23:07 Tx date 2020-06-23	$CPH Cipher Pharmaceuticals Inc.	Jutlah, Nadine 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-13,604.76 -11,934 vol $1.14 each	0
Filed 2020-06-16 14:16 Tx date 2020-06-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,587 +3,552 vol $1.01 each	249,424
Filed 2020-06-16 14:14 Tx date 2020-06-15	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$869.61 +861 vol $1.01 each	65,709
Filed 2020-05-29 16:53 Tx date 2020-05-26	$CPH Cipher Pharmaceuticals Inc.	Mull, Craig 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+806 vol	424,836
Filed 2020-05-29 16:52 Tx date 2020-05-26	$CPH Cipher Pharmaceuticals Inc.	Mull, Craig 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,500 vol	58,449
Filed 2020-05-29 16:51 Tx date 2020-05-26	$CPH Cipher Pharmaceuticals Inc.	Mull, John 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+478 vol	486,355
Filed 2020-05-29 16:50 Tx date 2020-05-26	$CPH Cipher Pharmaceuticals Inc.	Mull, John 3 - 10% Security Holder of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-866 vol	1,500
Filed 2020-05-29 16:49 Tx date 2020-05-26	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+866 vol	64,848
Filed 2020-05-29 16:48 Tx date 2020-05-26	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-866 vol	1,500
Filed 2020-05-29 16:46 Tx date 2020-05-26	$CPH Cipher Pharmaceuticals Inc.	Gajewczyk, Diane 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+1,059 vol	1,059
Filed 2020-05-29 16:46 Tx date 2018-06-04	$CPH Cipher Pharmaceuticals Inc.	Gajewczyk, Diane 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2020-05-29 16:45 Tx date 2020-05-26	$CPH Cipher Pharmaceuticals Inc.	Gajewczyk, Diane 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,916 vol	96,494
Filed 2020-05-29 16:41 Tx date 2020-05-26	$CPH Cipher Pharmaceuticals Inc.	Deboeck, Arthur Marie Joseph Ghislain 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+478 vol	245,040
Filed 2020-05-29 16:40 Tx date 2020-05-26	$CPH Cipher Pharmaceuticals Inc.	Deboeck, Arthur Marie Joseph Ghislain 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-866 vol	1,500
Filed 2020-05-29 16:35 Tx date 2020-05-26	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+478 vol	245,872
Filed 2020-05-29 16:34 Tx date 2020-05-26	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-866 vol	1,500
Filed 2020-05-29 16:32 Tx date 2020-05-26	$CPH Cipher Pharmaceuticals Inc.	Jutlah, Nadine 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+3,810 vol	11,934
Filed 2020-05-29 16:31 Tx date 2020-05-26	$CPH Cipher Pharmaceuticals Inc.	Jutlah, Nadine 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-6,891 vol	98,632
Filed 2020-05-20 16:40 Tx date 2020-05-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,632 +3,427 vol $1.06 each	245,394
Filed 2020-05-20 16:37 Tx date 2020-05-15	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$881.92 +832 vol $1.06 each	63,982
Filed 2020-05-11 17:00 Tx date 2020-05-07	$CPH Cipher Pharmaceuticals Inc.	Mull, Craig 4 - Director of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+1,500 vol	59,949
Filed 2020-05-11 16:58 Tx date 2020-05-07	$CPH Cipher Pharmaceuticals Inc.	Mull, Craig 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$3,150 +3,500 vol $0.90 each	63,901
Filed 2020-05-11 16:46 Tx date 2020-05-07	$CPH Cipher Pharmaceuticals Inc.	Deboeck, Arthur Marie Joseph Ghislain 4 - Director of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+1,500 vol	2,366
Filed 2020-05-11 16:44 Tx date 2020-05-07	$CPH Cipher Pharmaceuticals Inc.	Deboeck, Arthur Marie Joseph Ghislain 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$3,150 +3,500 vol $0.90 each	29,021
Filed 2020-05-11 16:42 Tx date 2020-05-07	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+1,500 vol	2,366
Filed 2020-05-11 16:32 Tx date 2020-05-07	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$3,150 +3,500 vol $0.90 each	32,521
Filed 2020-05-11 16:29 Tx date 2020-05-07	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+1,500 vol	2,366
Filed 2020-05-11 16:21 Tx date 2020-05-07	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$3,150 +3,500 vol $0.90 each	32,521
Filed 2020-05-11 16:19 Tx date 2020-05-07	$CPH Cipher Pharmaceuticals Inc.	Mull, John 3 - 10% Security Holder of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+1,500 vol	2,366
Filed 2020-05-11 16:16 Tx date 2020-05-07	$CPH Cipher Pharmaceuticals Inc.	Mull, John 3 - 10% Security Holder of Issuer Direct Ownership	Options 50 - Grant of options	$3,150 +3,500 vol $0.90 each	35,021
Filed 2020-04-21 09:23 Tx date 2020-04-16	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$883.50 +1,425 vol $0.62 each	63,150
Filed 2020-04-21 09:22 Tx date 2020-04-16	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,646 +5,882 vol $0.62 each	241,967
Filed 2020-04-21 09:19 Tx date 2020-04-16	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$912.64 +1,472 vol $0.62 each
Filed 2020-04-21 09:18 Tx date 2020-04-16	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$912.64 +1,472 vol $0.62 each
Filed 2020-04-12 10:32 Tx date 2020-04-08	$CPH Cipher Pharmaceuticals Inc.	Mull, Craig 4 - Director of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+56,449 vol	58,449
Filed 2020-04-12 10:31 Tx date 2020-04-08	$CPH Cipher Pharmaceuticals Inc.	Mull, Craig 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$29,088 +40,401 vol $0.72 each	60,401
Filed 2020-04-12 10:28 Tx date 2020-04-08	$CPH Cipher Pharmaceuticals Inc.	Gajewczyk, Diane 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+90,747 vol	98,410
Filed 2020-04-12 10:27 Tx date 2020-04-08	$CPH Cipher Pharmaceuticals Inc.	Gajewczyk, Diane 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$46,669 +64,819 vol $0.72 each	147,415
Filed 2020-04-12 10:24 Tx date 2020-04-08	$CPH Cipher Pharmaceuticals Inc.	Jutlah, Nadine 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+82,934 vol	105,523
Filed 2020-04-12 10:20 Tx date 2020-04-08	$CPH Cipher Pharmaceuticals Inc.	Jutlah, Nadine 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$42,652 +59,239 vol $0.72 each	114,538
Filed 2020-03-18 11:46 Tx date 2020-03-16	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,637 +6,062 vol $0.60 each	236,085
Filed 2020-03-18 11:44 Tx date 2020-03-16	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$883.20 +1,472 vol $0.60 each	61,725
Filed 2020-02-21 15:58 Tx date 2020-02-18	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,632 +4,224 vol $0.86 each	230,023
Filed 2020-02-21 15:57 Tx date 2020-02-18	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$882.36 +1,026 vol $0.86 each	60,253
Filed 2020-01-20 09:44 Tx date 2020-01-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,615 +3,411 vol $1.06 each	225,799
Filed 2020-01-20 09:43 Tx date 2020-01-15	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$882.98 +833 vol $1.06 each	59,227
Filed 2019-12-16 08:19 Tx date 2019-12-16	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,906 +4,651 vol $0.84 each	222,388
Filed 2019-12-16 08:16 Tx date 2019-12-16	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$882.00 +1,050 vol $0.84 each	58,394
Filed 2019-11-18 16:40 Tx date 2019-11-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,907 +3,757 vol $1.04 each	217,737
Filed 2019-11-18 16:39 Tx date 2019-11-15	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$881.92 +848 vol $1.04 each	57,344
Filed 2019-10-25 17:14 Tx date 2019-10-21	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,719 +3,476 vol $1.07 each	213,980
Filed 2019-10-25 17:13 Tx date 2019-10-21	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$880.61 +823 vol $1.07 each	56,496
Filed 2019-09-25 10:08 Tx date 2019-09-16	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,629 +2,975 vol $1.22 each	210,504
Filed 2019-09-25 10:08 Tx date 2019-08-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,637 +3,566 vol $1.02 each	207,529
Filed 2019-09-25 10:05 Tx date 2019-09-16	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$880.84 +722 vol $1.22 each	55,673
Filed 2019-09-25 10:04 Tx date 2019-08-15	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$881.28 +864 vol $1.02 each	51,951
Filed 2019-08-26 16:19 Tx date 2019-08-15	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$449.82 +441 vol $1.02 each
Filed 2019-08-26 15:42 Tx date 2019-08-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,279 +3,566 vol $1.20 each
Filed 2019-08-26 16:19 Tx date 2019-08-15	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$449.82 +441 vol $1.02 each	51,528
Filed 2019-08-26 15:42 Tx date 2019-08-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,279 +3,566 vol $1.20 each	207,529
Filed 2019-08-24 22:33 Tx date 2019-08-22	$CPH Cipher Pharmaceuticals Inc.	Deboeck, Arthur Marie Joseph Ghislain 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$23,674 +24,800 vol $0.95 each	244,562
Filed 2019-08-24 22:30 Tx date 2019-08-21	$CPH Cipher Pharmaceuticals Inc.	Deboeck, Arthur Marie Joseph Ghislain 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$10,492 +11,200 vol $0.94 each	219,762
Filed 2019-08-24 22:29 Tx date 2019-08-20	$CPH Cipher Pharmaceuticals Inc.	Deboeck, Arthur Marie Joseph Ghislain 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$17,046 +18,200 vol $0.94 each	208,562
Filed 2019-08-24 22:28 Tx date 2019-08-19	$CPH Cipher Pharmaceuticals Inc.	Deboeck, Arthur Marie Joseph Ghislain 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$17,015 +18,000 vol $0.95 each	190,362
Filed 2019-08-21 17:19 Tx date 2019-08-16	$CPH Cipher Pharmaceuticals Inc.	Deboeck, Arthur Marie Joseph Ghislain 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$20,704 +17,300 vol $1.20 each	172,362
Filed 2019-08-21 17:18 Tx date 2019-08-15	$CPH Cipher Pharmaceuticals Inc.	Deboeck, Arthur Marie Joseph Ghislain 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$59,200 +50,000 vol $1.18 each	155,062
Filed 2019-08-19 14:07 Tx date 2019-08-19	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$3,600 +3,000 vol $1.20 each	54,087
Filed 2019-08-09 12:09 Tx date 2019-08-08	$CPH Cipher Pharmaceuticals Inc.	Mull, Craig 4 - Director of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+2,000 vol	2,000
Filed 2019-08-09 12:07 Tx date 2019-03-26	$CPH Cipher Pharmaceuticals Inc.	Mull, Craig 4 - Director of Issuer Direct Ownership	Restricted Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2019-08-09 12:01 Tx date 2019-08-08	$CPH Cipher Pharmaceuticals Inc.	Mull, Craig 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$23,600 +20,000 vol $1.18 each	20,000
Filed 2019-08-09 11:58 Tx date 2019-03-26	$CPH Cipher Pharmaceuticals Inc.	Mull, Craig 4 - Director of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2019-07-22 20:27 Tx date 2019-07-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,385 +3,255 vol $1.04 each	203,963
Filed 2019-07-22 20:25 Tx date 2019-07-15	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$869.44 +836 vol $1.04 each	51,087
Filed 2019-06-28 09:50 Tx date 2019-06-28	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$3,960 +3,000 vol $1.32 each	50,251
Filed 2019-06-21 13:19 Tx date 2019-06-17	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$7,479 +7,262 vol $1.03 each	200,708
Filed 2019-06-21 13:14 Tx date 2019-06-17	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,707 +1,658 vol $1.03 each	43,251
Filed 2019-06-20 13:36 Tx date 2019-06-20	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$4,680 +4,000 vol $1.17 each	45,593
Filed 2019-04-26 09:02 Tx date 2019-03-21	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+866 vol	2,366
Filed 2019-04-26 08:55 Tx date 2019-03-21	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+2,021 vol	29,021
Filed 2019-04-23 22:30 Tx date 2019-04-11	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+866 vol	866
Filed 2019-04-23 22:29 Tx date 2019-04-11	$CPH Cipher Pharmaceuticals Inc.	Mull, John 3 - 10% Security Holder of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+866 vol	866
Filed 2019-04-23 22:28 Tx date 2019-04-11	$CPH Cipher Pharmaceuticals Inc.	Milloy, Michael 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+948 vol	948
Filed 2019-04-23 22:27 Tx date 2019-04-11	$CPH Cipher Pharmaceuticals Inc.	Gajewczyk, Diane 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+7,663 vol	7,663
Filed 2019-04-23 22:26 Tx date 2019-04-11	$CPH Cipher Pharmaceuticals Inc.	Watters, Chris 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+25,450 vol	47,461
Filed 2019-04-23 22:25 Tx date 2019-04-11	$CPH Cipher Pharmaceuticals Inc.	Tessarolo, Robert Dean 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+55,973 vol	96,697
Filed 2019-04-23 22:24 Tx date 2019-04-11	$CPH Cipher Pharmaceuticals Inc.	Deboeck, Arthur Marie Joseph Ghislain 4 - Director of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+866 vol	866
Filed 2019-04-23 22:23 Tx date 2019-04-11	$CPH Cipher Pharmaceuticals Inc.	Deboeck, Arthur Marie Joseph Ghislain 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$2,991 +2,021 vol $1.48 each	25,521
Filed 2019-04-23 22:22 Tx date 2019-04-11	$CPH Cipher Pharmaceuticals Inc.	Terrisse-Rulleau, Laurence 4 - Director of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+866 vol	866
Filed 2019-04-23 22:21 Tx date 2019-04-11	$CPH Cipher Pharmaceuticals Inc.	Terrisse-Rulleau, Laurence 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$2,991 +2,021 vol $1.48 each	22,021
Filed 2019-04-23 22:19 Tx date 2019-04-11	$CPH Cipher Pharmaceuticals Inc.	Jutlah, Nadine 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+12,846 vol	22,589
Filed 2019-04-23 22:19 Tx date 2019-04-11	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+866 vol	866
Filed 2019-04-23 22:18 Tx date 2019-04-11	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$2,991 +2,021 vol $1.48 each	29,021
Filed 2019-04-23 22:16 Tx date 2019-04-11	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Restricted Share Units 50 - Grant of options	+866 vol
Filed 2019-04-23 22:14 Tx date 2019-04-11	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$2,991 +2,021 vol $1.48 each	29,021
Filed 2019-04-23 22:12 Tx date 2019-04-11	$CPH Cipher Pharmaceuticals Inc.	Mull, John 3 - 10% Security Holder of Issuer Direct Ownership	Restricted Share Units 50 - Grant of options	+866 vol
Filed 2019-04-23 22:11 Tx date 2019-04-11	$CPH Cipher Pharmaceuticals Inc.	Mull, John 3 - 10% Security Holder of Issuer Direct Ownership	Options 50 - Grant of options	$2,991 +2,021 vol $1.48 each	31,521
Filed 2019-04-23 18:51 Tx date 2019-04-11	$CPH Cipher Pharmaceuticals Inc.	Milloy, Michael 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 50 - Grant of options	+948 vol
Filed 2019-04-23 18:51 Tx date 2019-04-11	$CPH Cipher Pharmaceuticals Inc.	Milloy, Michael 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 50 - Grant of options	+948 vol	948
Filed 2019-04-23 18:50 Tx date 2018-12-03	$CPH Cipher Pharmaceuticals Inc.	Milloy, Michael 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2019-04-23 18:50 Tx date 2019-04-11	$CPH Cipher Pharmaceuticals Inc.	Milloy, Michael 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$4,916 +3,322 vol $1.48 each	43,322
Filed 2019-04-23 18:48 Tx date 2019-04-11	$CPH Cipher Pharmaceuticals Inc.	Gajewczyk, Diane 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 50 - Grant of options	+7,663 vol
Filed 2019-04-23 18:48 Tx date 2019-04-11	$CPH Cipher Pharmaceuticals Inc.	Gajewczyk, Diane 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 50 - Grant of options	+7,663 vol	7,663
Filed 2019-04-23 18:48 Tx date 2018-06-04	$CPH Cipher Pharmaceuticals Inc.	Gajewczyk, Diane 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2019-04-23 18:47 Tx date 2019-04-11	$CPH Cipher Pharmaceuticals Inc.	Gajewczyk, Diane 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$39,745 +26,855 vol $1.48 each	82,596
Filed 2019-04-23 18:46 Tx date 2019-04-11	$CPH Cipher Pharmaceuticals Inc.	Watters, Chris 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 50 - Grant of options	+25,450 vol	47,461
Filed 2019-04-23 18:46 Tx date 2019-04-11	$CPH Cipher Pharmaceuticals Inc.	Watters, Chris 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 50 - Grant of options	+25,450 vol
Filed 2019-04-23 18:45 Tx date 2019-04-11	$CPH Cipher Pharmaceuticals Inc.	Watters, Chris 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$56,574 +38,226 vol $1.48 each	114,221
Filed 2019-04-23 18:44 Tx date 2019-04-11	$CPH Cipher Pharmaceuticals Inc.	Tessarolo, Robert Dean 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 50 - Grant of options	+55,973 vol	96,697
Filed 2019-04-23 18:44 Tx date 2019-04-11	$CPH Cipher Pharmaceuticals Inc.	Tessarolo, Robert Dean 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 50 - Grant of options	+55,973 vol
Filed 2019-04-23 18:42 Tx date 2019-04-11	$CPH Cipher Pharmaceuticals Inc.	Tessarolo, Robert Dean 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$290,327 +196,167 vol $1.48 each	484,181
Filed 2019-04-23 17:57 Tx date 2019-04-11	$CPH Cipher Pharmaceuticals Inc.	Tessarolo, Robert Dean 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$290,327 +196,167 vol $1.48 each	484,181
Filed 2019-04-23 17:57 Tx date 2019-04-11	$CPH Cipher Pharmaceuticals Inc.	Tessarolo, Robert Dean 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$290,327 +196,167 vol $1.48 each
Filed 2019-04-23 17:55 Tx date 2019-04-11	$CPH Cipher Pharmaceuticals Inc.	Jutlah, Nadine 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 50 - Grant of options	+12,846 vol
Filed 2019-04-23 17:55 Tx date 2019-04-11	$CPH Cipher Pharmaceuticals Inc.	Jutlah, Nadine 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 50 - Grant of options	+12,846 vol	22,589
Filed 2019-04-23 17:54 Tx date 2019-04-11	$CPH Cipher Pharmaceuticals Inc.	Jutlah, Nadine 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$28,556 +19,295 vol $1.48 each	55,299
Filed 2019-04-18 11:56 Tx date 2019-04-15	$CPH Cipher Pharmaceuticals Inc.	Jutlah, Nadine 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$100.28 +92 vol $1.09 each	8,124
Filed 2019-04-18 11:55 Tx date 2019-04-15	$CPH Cipher Pharmaceuticals Inc.	Watters, Chris 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$500.31 +459 vol $1.09 each	8,073
Filed 2019-04-18 11:54 Tx date 2019-04-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,522 +3,232 vol $1.09 each	193,446
Filed 2019-04-18 11:52 Tx date 2019-04-15	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$820.77 +753 vol $1.09 each	41,593
Filed 2019-04-18 10:31 Tx date 2019-04-01	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-1,077.48 -738 vol $1.46 each	94,922
Filed 2019-04-18 10:31 Tx date 2019-04-01	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-1,077.48 -738 vol $1.46 each	94,922
Filed 2019-04-18 10:27 Tx date 2019-04-01	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+1,500 vol	95,660
Filed 2019-04-18 10:27 Tx date 2019-04-01	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+1,500 vol	95,660
Filed 2019-04-18 10:24 Tx date 2019-04-01	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,500 vol	0
Filed 2019-04-18 10:24 Tx date 2019-04-01	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,500 vol	0
Filed 2019-04-18 10:13 Tx date 2019-04-15	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,946 +4,538 vol $1.09 each	99,460
Filed 2019-04-18 10:13 Tx date 2019-04-15	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,946 +4,538 vol $1.09 each	99,460
Filed 2019-04-17 13:26 Tx date 2019-04-01	$CPH Cipher Pharmaceuticals Inc.	Jutlah, Nadine 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+2,596 vol	8,032
Filed 2019-04-17 13:26 Tx date 2019-04-01	$CPH Cipher Pharmaceuticals Inc.	Jutlah, Nadine 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-5,102 vol	9,743
Filed 2019-04-17 13:11 Tx date 2019-04-01	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+1,500 vol	190,214
Filed 2019-04-17 13:10 Tx date 2019-04-01	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,500 vol	0
Filed 2019-04-17 13:09 Tx date 2019-04-01	$CPH Cipher Pharmaceuticals Inc.	Watters, Chris 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+2,635 vol	7,614
Filed 2019-04-17 13:08 Tx date 2019-04-01	$CPH Cipher Pharmaceuticals Inc.	Watters, Chris 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-5,187 vol	22,011
Filed 2019-04-17 13:06 Tx date 2019-04-01	$CPH Cipher Pharmaceuticals Inc.	Tessarolo, Robert Dean 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+7,593 vol	44,606
Filed 2019-04-17 13:04 Tx date 2019-04-01	$CPH Cipher Pharmaceuticals Inc.	Tessarolo, Robert Dean 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-14,947 vol	40,724
Filed 2019-04-17 12:53 Tx date 2019-04-01	$CPH Cipher Pharmaceuticals Inc.	Terrisse-Rulleau, Laurence 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+741 vol	741
Filed 2019-04-17 12:53 Tx date 2019-04-01	$CPH Cipher Pharmaceuticals Inc.	Terrisse-Rulleau, Laurence 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+741 vol
Filed 2019-04-17 12:52 Tx date 2018-05-11	$CPH Cipher Pharmaceuticals Inc.	Terrisse-Rulleau, Laurence 4 - Director of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2019-04-17 12:42 Tx date 2019-04-01	$CPH Cipher Pharmaceuticals Inc.	Terrisse-Rulleau, Laurence 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,500 vol	0
Filed 2019-04-17 12:40 Tx date 2019-04-01	$CPH Cipher Pharmaceuticals Inc.	Mull, John 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+762 vol	485,877
Filed 2019-04-17 12:37 Tx date 2019-04-01	$CPH Cipher Pharmaceuticals Inc.	Mull, John 3 - 10% Security Holder of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,500 vol	0
Filed 2019-04-17 12:36 Tx date 2019-04-01	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+762 vol	40,840
Filed 2019-04-17 12:35 Tx date 2019-04-01	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,500 vol	0
Filed 2019-04-17 12:32 Tx date 2019-04-01	$CPH Cipher Pharmaceuticals Inc.	Deboeck, Arthur Marie Joseph Ghislain 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,500 vol	0
Filed 2019-04-17 11:54 Tx date 2019-04-01	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+1,500 vol	41,578
Filed 2019-04-17 11:54 Tx date 2019-04-01	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+1,500 vol
Filed 2019-04-17 11:53 Tx date 2019-04-01	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,500 vol	0
Filed 2019-04-17 11:53 Tx date 2019-04-01	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,500 vol
Filed 2019-04-17 11:46 Tx date 2019-04-01	$CPH Cipher Pharmaceuticals Inc.	Deboeck, Arthur Marie Joseph Ghislain 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,500 vol	0
Filed 2019-04-17 11:46 Tx date 2019-04-01	$CPH Cipher Pharmaceuticals Inc.	Deboeck, Arthur Marie Joseph Ghislain 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,500 vol
Filed 2019-04-17 11:45 Tx date 2019-04-01	$CPH Cipher Pharmaceuticals Inc.	Deboeck, Arthur Marie Joseph Ghislain 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+762 vol	105,062
Filed 2019-04-17 11:43 Tx date 2019-04-01	$CPH Cipher Pharmaceuticals Inc.	Deboeck, Arthur Marie Joseph Ghislain 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,500 vol
Filed 2019-04-17 11:43 Tx date 2019-04-01	$CPH Cipher Pharmaceuticals Inc.	Deboeck, Arthur Marie Joseph Ghislain 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,500 vol
Filed 2019-04-02 21:05 Tx date 2019-03-29	$CPH Cipher Pharmaceuticals Inc.	Jutlah, Nadine 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report		5,436
Filed 2019-04-02 20:56 Tx date 2019-03-29	$CPH Cipher Pharmaceuticals Inc.	Jutlah, Nadine 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 00 - Opening Balance-Initial SEDI Report		14,845
Filed 2019-04-02 20:54 Tx date 2019-03-29	$CPH Cipher Pharmaceuticals Inc.	Jutlah, Nadine 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report		36,004
Filed 2019-04-01 Tx date 2019-03-26	$CPH Cipher Pharmaceuticals Inc.	Mull, Craig 4 - Director of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report		424,030
Filed 2019-03-20 Tx date 2019-03-15	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$5,040 +3,231 vol $1.56 each	94,160
Filed 2019-03-19 Tx date 2019-03-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,625 +2,324 vol $1.56 each	188,714
Filed 2019-03-19 Tx date 2019-03-15	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$847.08 +543 vol $1.56 each	40,078
Filed 2019-03-19 Tx date 2019-03-15	$CPH Cipher Pharmaceuticals Inc.	Watters, Chris 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$499.20 +320 vol $1.56 each	4,979
Filed 2019-03-19 Tx date 2019-03-15	$CPH Cipher Pharmaceuticals Inc.	Lemieux, Stephen 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$299.52 +192 vol $1.56 each	24,550
Filed 2019-02-20 Tx date 2019-02-15	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$5,053 +3,139 vol $1.61 each	90,929
Filed 2019-02-19 Tx date 2019-02-15	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$846.86 +526 vol $1.61 each	39,535
Filed 2019-02-19 Tx date 2019-02-15	$CPH Cipher Pharmaceuticals Inc.	Lemieux, Stephen 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$299.46 +186 vol $1.61 each	24,358
Filed 2019-02-19 Tx date 2019-02-15	$CPH Cipher Pharmaceuticals Inc.	Watters, Chris 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$500.71 +311 vol $1.61 each	4,659
Filed 2019-02-19 Tx date 2019-02-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,632 +2,256 vol $1.61 each	186,390
Filed 2019-01-17 Tx date 2019-01-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,611 +2,189 vol $1.65 each	184,134
Filed 2019-01-17 Tx date 2019-01-15	$CPH Cipher Pharmaceuticals Inc.	Lemieux, Stephen 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,262 +765 vol $1.65 each	24,172
Filed 2019-01-17 Tx date 2019-01-15	$CPH Cipher Pharmaceuticals Inc.	Watters, Chris 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$499.95 +303 vol $1.65 each	4,348
Filed 2019-01-17 Tx date 2019-01-15	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$846.45 +513 vol $1.65 each	39,009
Filed 2019-01-17 Tx date 2019-01-15	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$5,012 +3,038 vol $1.65 each	87,790
Filed 2018-12-21 Tx date 2018-12-21	$CPH Cipher Pharmaceuticals Inc.	Mull, John 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$85,000 +50,000 vol $1.70 each	485,115
Filed 2018-12-21 Tx date 2018-12-20	$CPH Cipher Pharmaceuticals Inc.	Mull, John 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$68,000 +40,000 vol $1.70 each	435,115
Filed 2018-12-20 Tx date 2018-12-19	$CPH Cipher Pharmaceuticals Inc.	Mull, John 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$17,100 +10,000 vol $1.71 each	395,115
Filed 2018-12-20 Tx date 2018-12-17	$CPH Cipher Pharmaceuticals Inc.	Watters, Chris 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$499.81 +331 vol $1.51 each	4,045
Filed 2018-12-20 Tx date 2018-12-17	$CPH Cipher Pharmaceuticals Inc.	Lemieux, Stephen 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,262 +836 vol $1.51 each	23,407
Filed 2018-12-20 Tx date 2018-12-17	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$5,392 +3,571 vol $1.51 each	84,752
Filed 2018-12-20 Tx date 2018-12-17	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,871 +2,564 vol $1.51 each	181,945
Filed 2018-12-20 Tx date 2018-12-17	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$892.41 +591 vol $1.51 each	38,496
Filed 2018-12-18 Tx date 2018-12-14	$CPH Cipher Pharmaceuticals Inc.	Milloy, Michael 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$70,000 +40,000 vol $1.75 each	40,000
Filed 2018-12-18 Tx date 2018-12-03	$CPH Cipher Pharmaceuticals Inc.	Milloy, Michael 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2018-11-20 Tx date 2018-11-15	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$5,398 +3,575 vol $1.51 each	81,181
Filed 2018-11-20 Tx date 2018-11-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,873 +2,565 vol $1.51 each	179,381
Filed 2018-11-20 Tx date 2018-11-15	$CPH Cipher Pharmaceuticals Inc.	Lemieux, Stephen 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,262 +836 vol $1.51 each
Filed 2018-11-20 Tx date 2018-11-15	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$845.60 +560 vol $1.51 each	37,905
Filed 2018-11-20 Tx date 2018-11-15	$CPH Cipher Pharmaceuticals Inc.	Lemieux, Stephen 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,262 +836 vol $1.51 each	22,571
Filed 2018-11-20 Tx date 2018-11-15	$CPH Cipher Pharmaceuticals Inc.	Watters, Chris 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$499.81 +331 vol $1.51 each	3,714
Filed 2018-10-19 Tx date 2018-10-15	$CPH Cipher Pharmaceuticals Inc.	Lemieux, Stephen 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,262 +495 vol $2.55 each	21,735
Filed 2018-10-19 Tx date 2018-10-15	$CPH Cipher Pharmaceuticals Inc.	Watters, Chris 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$499.80 +196 vol $2.55 each	3,383
Filed 2018-10-19 Tx date 2018-10-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,886 +1,524 vol $2.55 each	176,816
Filed 2018-10-19 Tx date 2018-10-15	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$846.60 +332 vol $2.55 each	37,345
Filed 2018-10-19 Tx date 2018-10-15	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$5,398 +2,117 vol $2.55 each	77,606
Filed 2018-09-20 Tx date 2018-09-17	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$5,395 +1,934 vol $2.79 each	75,489
Filed 2018-09-19 Tx date 2018-09-17	$CPH Cipher Pharmaceuticals Inc.	Watters, Chris 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$463.61 +179 vol $2.59 each
Filed 2018-09-19 Tx date 2018-09-17	$CPH Cipher Pharmaceuticals Inc.	Lemieux, Stephen 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,263 +453 vol $2.79 each	21,240
Filed 2018-09-19 Tx date 2018-09-17	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,674 +1,317 vol $2.79 each	175,292
Filed 2018-09-19 Tx date 2018-09-17	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$845.37 +303 vol $2.79 each	37,013
Filed 2018-09-19 Tx date 2018-09-17	$CPH Cipher Pharmaceuticals Inc.	Watters, Chris 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$499.41 +179 vol $2.79 each	3,187
Filed 2018-08-28 Tx date 2018-08-23	$CPH Cipher Pharmaceuticals Inc.	Watters, Chris 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-2,151 vol	27,198
Filed 2018-08-28 Tx date 2018-08-23	$CPH Cipher Pharmaceuticals Inc.	Watters, Chris 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+2,151 vol	3,008
Filed 2018-08-20 Tx date 2018-08-15	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$5,394 +2,083 vol $2.59 each	73,555
Filed 2018-08-20 Tx date 2018-08-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,623 +1,399 vol $2.59 each	173,975
Filed 2018-08-20 Tx date 2018-08-15	$CPH Cipher Pharmaceuticals Inc.	Watters, Chris 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$499.87 +193 vol $2.59 each	857
Filed 2018-08-20 Tx date 2018-08-14	$CPH Cipher Pharmaceuticals Inc.	Terrisse-Rulleau, Laurence 4 - Director of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+1,500 vol	1,500
Filed 2018-08-20 Tx date 2018-05-11	$CPH Cipher Pharmaceuticals Inc.	Terrisse-Rulleau, Laurence 4 - Director of Issuer Direct Ownership	Restricted Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2018-08-20 Tx date 2018-08-15	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$844.34 +326 vol $2.59 each	36,710
Filed 2018-08-20 Tx date 2018-08-15	$CPH Cipher Pharmaceuticals Inc.	Lemieux, Stephen 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,263 +488 vol $2.59 each	20,787
Filed 2018-08-20 Tx date 2018-05-11	$CPH Cipher Pharmaceuticals Inc.	Terrisse-Rulleau, Laurence 4 - Director of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2018-08-20 Tx date 2018-08-14	$CPH Cipher Pharmaceuticals Inc.	Terrisse-Rulleau, Laurence 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$60,800 +20,000 vol $3.04 each	20,000
Filed 2018-08-15 Tx date 2018-08-15	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$5,600 +2,000 vol $2.80 each	36,384
Filed 2018-08-14 Tx date 2018-06-04	$CPH Cipher Pharmaceuticals Inc.	Gajewczyk, Diane 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2018-08-14 Tx date 2018-08-14	$CPH Cipher Pharmaceuticals Inc.	Gajewczyk, Diane 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$169,452 +55,741 vol $3.04 each	55,741
Filed 2018-07-20 Tx date 2018-07-16	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$5,416 +2,276 vol $2.38 each	71,472
Filed 2018-07-19 Tx date 2018-07-16	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,619 +1,521 vol $2.38 each	172,576
Filed 2018-07-19 Tx date 2018-07-16	$CPH Cipher Pharmaceuticals Inc.	Watters, Chris 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$499.80 +210 vol $2.38 each	664
Filed 2018-07-19 Tx date 2018-07-16	$CPH Cipher Pharmaceuticals Inc.	Lemieux, Stephen 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,261 +530 vol $2.38 each	20,299
Filed 2018-07-19 Tx date 2018-07-16	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$844.90 +355 vol $2.38 each	34,384
Filed 2018-07-05 Tx date 2018-06-25	$CPH Cipher Pharmaceuticals Inc.	Lemieux, Stephen 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$9,993 +3,582 vol $2.79 each	19,769
Filed 2018-07-05 Tx date 2018-06-25	$CPH Cipher Pharmaceuticals Inc.	Lemieux, Stephen 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 57 - Exercise of rights	-3,582 vol	23,216
Filed 2018-07-02 Tx date 2018-06-28	$CPH Cipher Pharmaceuticals Inc.	Mull, John 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$22,620 +7,800 vol $2.90 each	385,115
Filed 2018-06-28 Tx date 2018-06-25	$CPH Cipher Pharmaceuticals Inc.	Mull, John 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$28,000 +10,000 vol $2.80 each	377,315
Filed 2018-06-26 Tx date 2018-06-22	$CPH Cipher Pharmaceuticals Inc.	Mull, John 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$6,050 +2,200 vol $2.75 each	367,315
Filed 2018-06-22 Tx date 2018-06-22	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$5,700 +2,000 vol $2.85 each	34,029
Filed 2018-06-21 Tx date 2018-06-21	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$5,700 +2,000 vol $2.85 each	32,029
Filed 2018-06-19 Tx date 2018-06-15	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$5,128 +2,220 vol $2.31 each	69,196
Filed 2018-06-19 Tx date 2018-06-15	$CPH Cipher Pharmaceuticals Inc.	Lemieux, Stephen 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,263 +547 vol $2.31 each	16,187
Filed 2018-06-19 Tx date 2018-06-15	$CPH Cipher Pharmaceuticals Inc.	Watters, Chris 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$498.96 +216 vol $2.31 each	454
Filed 2018-06-19 Tx date 2018-06-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,640 +1,576 vol $2.31 each	171,055
Filed 2018-06-19 Tx date 2018-06-15	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$845.46 +366 vol $2.31 each	30,029
Filed 2018-06-08 Tx date 2018-06-08	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$5,430 +2,000 vol $2.71 each	29,663
Filed 2018-06-05 Tx date 2018-06-05	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$6,100 +2,000 vol $3.05 each	27,663
Filed 2018-05-21 Tx date 2018-05-15	$CPH Cipher Pharmaceuticals Inc.	Lemieux, Stephen 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,262 +425 vol $2.97 each	15,640
Filed 2018-05-21 Tx date 2018-05-15	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$778.14 +262 vol $2.97 each	20,663
Filed 2018-05-21 Tx date 2018-05-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,356 +1,130 vol $2.97 each	169,479
Filed 2018-05-21 Tx date 2018-05-15	$CPH Cipher Pharmaceuticals Inc.	Watters, Chris 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$498.96 +168 vol $2.97 each	238
Filed 2018-05-18 Tx date 2018-05-15	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,754 +1,601 vol $2.97 each	66,976
Filed 2018-05-17 Tx date 2018-05-17	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$17,925 +5,000 vol $3.58 each	25,401
Filed 2018-04-20 Tx date 2018-04-16	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$844.88 +236 vol $3.58 each	20,401
Filed 2018-04-20 Tx date 2018-04-16	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$5,029 +1,405 vol $3.58 each	65,375
Filed 2018-04-20 Tx date 2017-06-12	$CPH Cipher Pharmaceuticals Inc.	Watters, Chris 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2018-04-20 Tx date 2018-04-16	$CPH Cipher Pharmaceuticals Inc.	Lemieux, Stephen 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,263 +353 vol $3.58 each	15,215
Filed 2018-04-20 Tx date 2018-04-16	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,622 +1,012 vol $3.58 each	168,349
Filed 2018-04-20 Tx date 2018-04-16	$CPH Cipher Pharmaceuticals Inc.	Watters, Chris 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$250.60 +70 vol $3.58 each	70
Filed 2018-04-08 Tx date 2018-04-05	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+1,500 vol	63,970
Filed 2018-04-08 Tx date 2018-04-05	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,500 vol	1,500
Filed 2018-04-06 Tx date 2018-04-03	$CPH Cipher Pharmaceuticals Inc.	Lemieux, Stephen 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$17,025 +4,769 vol $3.57 each
Filed 2018-04-06 Tx date 2018-04-03	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,500 vol	1,500
Filed 2018-04-06 Tx date 2018-04-03	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+1,500 vol	167,337
Filed 2018-04-06 Tx date 2018-04-03	$CPH Cipher Pharmaceuticals Inc.	Tessarolo, Robert Dean 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-4,113 vol	55,671
Filed 2018-04-06 Tx date 2018-04-03	$CPH Cipher Pharmaceuticals Inc.	Tessarolo, Robert Dean 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,500 vol
Filed 2018-04-06 Tx date 2018-04-03	$CPH Cipher Pharmaceuticals Inc.	Tessarolo, Robert Dean 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,500 vol
Filed 2018-04-06 Tx date 2018-04-03	$CPH Cipher Pharmaceuticals Inc.	Tessarolo, Robert Dean 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+4,113 vol	37,013
Filed 2018-04-06 Tx date 2018-04-03	$CPH Cipher Pharmaceuticals Inc.	Mull, John 3 - 10% Security Holder of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,500 vol	1,500
Filed 2018-04-06 Tx date 2018-04-03	$CPH Cipher Pharmaceuticals Inc.	Mull, John 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+1,500 vol	365,115
Filed 2018-04-06 Tx date 2018-04-03	$CPH Cipher Pharmaceuticals Inc.	Lemieux, Stephen 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-3,582 vol	40,096
Filed 2018-04-06 Tx date 2018-04-03	$CPH Cipher Pharmaceuticals Inc.	Lemieux, Stephen 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-4,769 vol	43,678
Filed 2018-04-06 Tx date 2018-04-03	$CPH Cipher Pharmaceuticals Inc.	Lemieux, Stephen 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-4,769 vol
Filed 2018-04-06 Tx date 2018-04-03	$CPH Cipher Pharmaceuticals Inc.	Lemieux, Stephen 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+3,582 vol	14,862
Filed 2018-04-06 Tx date 2018-04-03	$CPH Cipher Pharmaceuticals Inc.	Lemieux, Stephen 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+4,769 vol	11,280
Filed 2018-04-06 Tx date 2018-04-03	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,500 vol	1,500
Filed 2018-04-06 Tx date 2018-04-03	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+1,500 vol	20,165
Filed 2018-04-06 Tx date 2018-04-03	$CPH Cipher Pharmaceuticals Inc.	Deboeck, Arthur Marie Joseph Ghislain 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,500 vol	1,500
Filed 2018-04-06 Tx date 2018-04-03	$CPH Cipher Pharmaceuticals Inc.	Deboeck, Arthur Marie Joseph Ghislain 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+1,500 vol	104,300
Filed 2018-03-28 Tx date 2018-03-22	$CPH Cipher Pharmaceuticals Inc.	Mull, John 3 - 10% Security Holder of Issuer Direct Ownership	Options 50 - Grant of options	$12,355 +3,500 vol $3.53 each	29,500
Filed 2018-03-28 Tx date 2018-03-22	$CPH Cipher Pharmaceuticals Inc.	Mull, John 3 - 10% Security Holder of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+1,500 vol	3,000
Filed 2018-03-26 Tx date 2018-03-22	$CPH Cipher Pharmaceuticals Inc.	Watters, Chris 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$143,406 +40,625 vol $3.53 each	75,995
Filed 2018-03-26 Tx date 2018-03-22	$CPH Cipher Pharmaceuticals Inc.	Watters, Chris 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$143,406 +40,625 vol $3.53 each
Filed 2018-03-26 Tx date 2018-03-22	$CPH Cipher Pharmaceuticals Inc.	Tessarolo, Robert Dean 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+43,334 vol	59,784
Filed 2018-03-26 Tx date 2018-03-22	$CPH Cipher Pharmaceuticals Inc.	Tessarolo, Robert Dean 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$698,989 +198,014 vol $3.53 each	288,014
Filed 2018-03-26 Tx date 2018-03-22	$CPH Cipher Pharmaceuticals Inc.	Lemieux, Stephen 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+22,213 vol	48,447
Filed 2018-03-26 Tx date 2018-03-22	$CPH Cipher Pharmaceuticals Inc.	Lemieux, Stephen 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$358,295 +101,500 vol $3.53 each	226,544
Filed 2018-03-26 Tx date 2018-03-22	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+1,500 vol	3,000
Filed 2018-03-26 Tx date 2018-03-22	$CPH Cipher Pharmaceuticals Inc.	Watters, Chris 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+20,745 vol	29,349
Filed 2018-03-26 Tx date 2018-03-22	$CPH Cipher Pharmaceuticals Inc.	Deboeck, Arthur Marie Joseph Ghislain 4 - Director of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+1,500 vol	3,000
Filed 2018-03-26 Tx date 2018-03-22	$CPH Cipher Pharmaceuticals Inc.	Deboeck, Arthur Marie Joseph Ghislain 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$12,355 +3,500 vol $3.53 each	23,500
Filed 2018-03-26 Tx date 2018-03-22	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+1,500 vol	3,000
Filed 2018-03-26 Tx date 2018-03-22	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$12,355 +3,500 vol $3.53 each	27,000
Filed 2018-03-26 Tx date 2018-03-22	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$12,355 +3,500 vol $3.53 each	27,000
Filed 2018-03-26 Tx date 2018-03-22	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+1,500 vol	3,000
Filed 2018-03-26 Tx date 2018-03-22	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$12,355 +3,500 vol $3.53 each	27,000
Filed 2018-03-26 Tx date 2018-03-22	$CPH Cipher Pharmaceuticals Inc.	Watters, Chris 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+20,745 vol
Filed 2018-03-23 Tx date 2018-03-22	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$181,500 +50,000 vol $3.63 each	165,837
Filed 2018-03-23 Tx date 2018-03-22	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$47,190 +13,000 vol $3.63 each	18,665
Filed 2018-03-20 Tx date 2018-03-15	$CPH Cipher Pharmaceuticals Inc.	Lemieux, Stephen 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,206 +357 vol $3.38 each	6,511
Filed 2018-03-20 Tx date 2018-03-15	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$845.00 +250 vol $3.38 each	5,665
Filed 2018-03-20 Tx date 2018-03-15	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$5,029 +1,488 vol $3.38 each	62,470
Filed 2018-03-20 Tx date 2018-03-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,623 +1,072 vol $3.38 each	115,837
Filed 2018-02-20 Tx date 2018-02-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,621 +1,059 vol $3.42 each	114,765
Filed 2018-02-20 Tx date 2018-02-15	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$844.74 +247 vol $3.42 each	5,415
Filed 2018-02-20 Tx date 2018-02-15	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$5,023 +1,469 vol $3.42 each	60,982
Filed 2018-02-20 Tx date 2018-02-15	$CPH Cipher Pharmaceuticals Inc.	Lemieux, Stephen 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,207 +353 vol $3.42 each	6,154
Filed 2018-01-19 Tx date 2018-01-15	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,995 +1,350 vol $3.70 each	59,513
Filed 2018-01-17 Tx date 2018-01-15	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$847.30 +229 vol $3.70 each	5,168
Filed 2018-01-17 Tx date 2018-01-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,607 +975 vol $3.70 each	113,706
Filed 2018-01-17 Tx date 2018-01-15	$CPH Cipher Pharmaceuticals Inc.	Lemieux, Stephen 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,206 +326 vol $3.70 each	5,801
Filed 2017-12-20 Tx date 2017-12-15	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$5,373 +1,357 vol $3.96 each	58,163
Filed 2017-12-19 Tx date 2017-12-15	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$784.08 +198 vol $3.96 each	4,939
Filed 2017-12-19 Tx date 2017-12-15	$CPH Cipher Pharmaceuticals Inc.	Lemieux, Stephen 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,207 +305 vol $3.96 each	5,475
Filed 2017-12-19 Tx date 2017-12-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,864 +976 vol $3.96 each	112,731
Filed 2017-11-19 Tx date 2017-11-15	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$5,376 +1,393 vol $3.86 each	56,806
Filed 2017-11-17 Tx date 2017-11-15	$CPH Cipher Pharmaceuticals Inc.	Lemieux, Stephen 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,208 +313 vol $3.86 each	5,170
Filed 2017-11-17 Tx date 2017-11-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,875 +1,004 vol $3.86 each	111,755
Filed 2017-11-17 Tx date 2017-11-15	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$841.48 +218 vol $3.86 each	4,741
Filed 2017-11-11 Tx date 2017-11-10	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$164,150 +35,000 vol $4.69 each	110,751
Filed 2017-10-20 Tx date 2017-10-16	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,698 +981 vol $3.77 each	75,751
Filed 2017-10-20 Tx date 2017-10-16	$CPH Cipher Pharmaceuticals Inc.	Lemieux, Stephen 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,206 +320 vol $3.77 each	4,857
Filed 2017-10-20 Tx date 2017-10-16	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$840.71 +223 vol $3.77 each	4,523
Filed 2017-10-19 Tx date 2017-10-16	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$5,383 +1,428 vol $3.77 each	55,413
Filed 2017-09-25 Tx date 2017-09-20	$CPH Cipher Pharmaceuticals Inc.	Watters, Chris 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 56 - Grant of rights	+9,594 vol	9,594
Filed 2017-09-25 Tx date 2017-06-12	$CPH Cipher Pharmaceuticals Inc.	Watters, Chris 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2017-09-25 Tx date 2017-09-20	$CPH Cipher Pharmaceuticals Inc.	Tessarolo, Robert Dean 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 56 - Grant of rights	+29,151 vol	29,151
Filed 2017-09-25 Tx date 2017-04-17	$CPH Cipher Pharmaceuticals Inc.	Tessarolo, Robert Dean 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2017-09-25 Tx date 2017-09-20	$CPH Cipher Pharmaceuticals Inc.	Lemieux, Stephen 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 56 - Grant of rights	+16,052 vol	26,798
Filed 2017-09-25 Tx date 2017-09-20	$CPH Cipher Pharmaceuticals Inc.	Angaritis, Linda Melanie 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 56 - Grant of rights	+8,485 vol	13,907
Filed 2017-09-19 Tx date 2017-09-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,613 +899 vol $4.02 each	74,770
Filed 2017-09-19 Tx date 2017-09-15	$CPH Cipher Pharmaceuticals Inc.	Lemieux, Stephen 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,205 +300 vol $4.02 each	4,537
Filed 2017-09-19 Tx date 2017-09-15	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$844.20 +210 vol $4.02 each	4,300
Filed 2017-09-19 Tx date 2017-09-15	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$5,242 +1,304 vol $4.02 each	53,985
Filed 2017-09-14 Tx date 2017-08-15	$CPH Cipher Pharmaceuticals Inc.	Watters, Chris 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$185,338 +35,370 vol $5.24 each	35,370
Filed 2017-09-14 Tx date 2017-06-12	$CPH Cipher Pharmaceuticals Inc.	Watters, Chris 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2017-09-14 Tx date 2017-06-12	$CPH Cipher Pharmaceuticals Inc.	Watters, Chris 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2017-09-14 Tx date 2017-08-22	$CPH Cipher Pharmaceuticals Inc.	Watters, Chris 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+8,604 vol
Filed 2017-09-14 Tx date 2017-08-22	$CPH Cipher Pharmaceuticals Inc.	Watters, Chris 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+8,604 vol	8,604
Filed 2017-08-20 Tx date 2017-08-15	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$5,013 +1,097 vol $4.57 each	52,681
Filed 2017-08-18 Tx date 2017-08-15	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$840.88 +184 vol $4.57 each	4,090
Filed 2017-08-18 Tx date 2017-08-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,614 +791 vol $4.57 each	73,871
Filed 2017-08-18 Tx date 2017-08-15	$CPH Cipher Pharmaceuticals Inc.	Lemieux, Stephen 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,206 +264 vol $4.57 each	4,237
Filed 2017-07-22 Tx date 2017-07-17	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,876 +1,060 vol $4.60 each	51,584
Filed 2017-07-20 Tx date 2017-07-17	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,610 +785 vol $4.60 each	73,080
Filed 2017-07-20 Tx date 2017-07-17	$CPH Cipher Pharmaceuticals Inc.	Lemieux, Stephen 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,209 +263 vol $4.60 each	3,973
Filed 2017-07-20 Tx date 2017-07-17	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$841.80 +183 vol $4.60 each	3,906
Filed 2017-07-04 Tx date 2017-06-30	$CPH Cipher Pharmaceuticals Inc.	Mull, John 3 - 10% Security Holder of Issuer Holder: 1207407 Ontario Limited (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$10,830 +1,900 vol $5.70 each	9,436,150
Filed 2017-06-29 Tx date 2017-06-28	$CPH Cipher Pharmaceuticals Inc.	Mull, John 3 - 10% Security Holder of Issuer Holder: 1207407 Ontario Limited (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$47,311 +8,500 vol $5.57 each	9,434,250
Filed 2017-06-27 Tx date 2017-06-21	$CPH Cipher Pharmaceuticals Inc.	Mull, John 3 - 10% Security Holder of Issuer Holder: 1207407 Ontario Limited (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$22,533 +4,100 vol $5.50 each	9,425,750
Filed 2017-06-27 Tx date 2017-06-20	$CPH Cipher Pharmaceuticals Inc.	Mull, John 3 - 10% Security Holder of Issuer Holder: 1207407 Ontario Limited (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$11,550 +2,100 vol $5.50 each	9,421,650
Filed 2017-06-20 Tx date 2017-06-16	$CPH Cipher Pharmaceuticals Inc.	Mull, John 3 - 10% Security Holder of Issuer Holder: 1207407 Ontario Limited (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$18,870 +3,400 vol $5.55 each	9,419,550
Filed 2017-06-20 Tx date 2017-06-15	$CPH Cipher Pharmaceuticals Inc.	Mull, John 3 - 10% Security Holder of Issuer Holder: 1207407 Ontario Limited (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$36,075 +6,500 vol $5.55 each	9,416,150
Filed 2017-06-19 Tx date 2017-06-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,612 +767 vol $4.71 each	72,295
Filed 2017-06-19 Tx date 2017-06-15	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$6,382 +1,355 vol $4.71 each	50,524
Filed 2017-06-19 Tx date 2017-06-15	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$942.00 +200 vol $4.71 each	3,723
Filed 2017-06-19 Tx date 2017-06-15	$CPH Cipher Pharmaceuticals Inc.	Lemieux, Stephen 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$602.88 +128 vol $4.71 each	3,710
Filed 2017-06-15 Tx date 2017-06-14	$CPH Cipher Pharmaceuticals Inc.	Mull, John 3 - 10% Security Holder of Issuer Holder: 1207407 Ontario Limited (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$26,640 +4,800 vol $5.55 each	9,405,950
Filed 2017-06-15 Tx date 2017-06-13	$CPH Cipher Pharmaceuticals Inc.	Mull, John 3 - 10% Security Holder of Issuer Holder: 1207407 Ontario Limited (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$27,750 +5,000 vol $5.55 each	9,401,150
Filed 2017-06-15 Tx date 2017-06-14	$CPH Cipher Pharmaceuticals Inc.	Mull, John 3 - 10% Security Holder of Issuer Holder: 1207407 Ontario Limited (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$20,535 +3,700 vol $5.55 each	9,409,650
Filed 2017-06-13 Tx date 2017-06-09	$CPH Cipher Pharmaceuticals Inc.	Mull, John 3 - 10% Security Holder of Issuer Holder: 1207407 Ontario Limited (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$27,500 +5,000 vol $5.50 each
Filed 2017-06-13 Tx date 2017-06-12	$CPH Cipher Pharmaceuticals Inc.	Mull, John 3 - 10% Security Holder of Issuer Holder: 1207407 Ontario Limited (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$27,750 +5,000 vol $5.55 each	9,396,150
Filed 2017-06-13 Tx date 2017-06-09	$CPH Cipher Pharmaceuticals Inc.	Mull, John 3 - 10% Security Holder of Issuer Holder: 1207407 Ontario Limited (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$27,750 +5,000 vol $5.55 each	9,391,150
Filed 2017-06-07 Tx date 2017-06-06	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$7,910 +1,400 vol $5.65 each	49,169
Filed 2017-06-05 Tx date 2017-06-05	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$105,090 +18,600 vol $5.65 each	47,769
Filed 2017-05-30 Tx date 2017-05-30	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$83,518 +15,000 vol $5.57 each	71,528
Filed 2017-05-26 Tx date 2017-05-23	$CPH Cipher Pharmaceuticals Inc.	Lemieux, Stephen 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+19,070 vol	26,234
Filed 2017-05-26 Tx date 2017-05-23	$CPH Cipher Pharmaceuticals Inc.	Angaritis, Linda Melanie 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+5,906 vol	9,520
Filed 2017-05-26 Tx date 2017-05-11	$CPH Cipher Pharmaceuticals Inc.	Deboeck, Arthur Marie Joseph Ghislain 4 - Director of Issuer Direct Ownership	Restricted Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2017-05-26 Tx date 2017-05-23	$CPH Cipher Pharmaceuticals Inc.	Deboeck, Arthur Marie Joseph Ghislain 4 - Director of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+1,500 vol	1,500
Filed 2017-05-26 Tx date 2017-05-23	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+1,500 vol	1,500
Filed 2017-05-26 Tx date 2017-04-17	$CPH Cipher Pharmaceuticals Inc.	Tessarolo, Robert Dean 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2017-05-26 Tx date 2017-05-23	$CPH Cipher Pharmaceuticals Inc.	Tessarolo, Robert Dean 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+16,450 vol	16,450
Filed 2017-05-26 Tx date 2017-05-23	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+1,500 vol	1,500
Filed 2017-05-24 Tx date 2017-05-23	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+1,500 vol	1,500
Filed 2017-05-19 Tx date 2017-05-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,615 +833 vol $4.34 each	22,328
Filed 2017-05-19 Tx date 2017-05-15	$CPH Cipher Pharmaceuticals Inc.	Weiler, Peter John 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$129,743 +25,641 vol $5.06 each
Filed 2017-05-19 Tx date 2017-05-15	$CPH Cipher Pharmaceuticals Inc.	Weiler, Peter John 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$129,743 +25,641 vol $5.06 each	105,531
Filed 2017-05-19 Tx date 2017-05-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$17,710 +3,500 vol $5.06 each	23,500
Filed 2017-05-19 Tx date 2017-05-15	$CPH Cipher Pharmaceuticals Inc.	Bulger, Lynne Cheryl 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$130,249 +25,741 vol $5.06 each	59,173
Filed 2017-05-19 Tx date 2017-05-15	$CPH Cipher Pharmaceuticals Inc.	Chypyha, Joan 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$302,906 +59,863 vol $5.06 each	212,787
Filed 2017-05-19 Tx date 2017-05-15	$CPH Cipher Pharmaceuticals Inc.	Angaritis, Linda Melanie 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$136,893 +27,054 vol $5.06 each	117,044
Filed 2017-05-19 Tx date 2017-05-11	$CPH Cipher Pharmaceuticals Inc.	Deboeck, Arthur Marie Joseph Ghislain 4 - Director of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2017-05-19 Tx date 2017-05-15	$CPH Cipher Pharmaceuticals Inc.	Deboeck, Arthur Marie Joseph Ghislain 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$101,199 +20,000 vol $5.06 each	20,000
Filed 2017-05-19 Tx date 2017-05-15	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$707.42 +163 vol $4.34 each	3,523
Filed 2017-05-19 Tx date 2017-05-15	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$17,710 +3,500 vol $5.06 each	23,500
Filed 2017-05-19 Tx date 2017-05-15	$CPH Cipher Pharmaceuticals Inc.	Lemieux, Stephen 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$442,056 +87,363 vol $5.06 each	125,044
Filed 2017-05-19 Tx date 2017-04-17	$CPH Cipher Pharmaceuticals Inc.	Tessarolo, Robert Dean 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2017-05-19 Tx date 2017-05-15	$CPH Cipher Pharmaceuticals Inc.	Tessarolo, Robert Dean 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$455,399 +90,000 vol $5.06 each	90,000
Filed 2017-05-18 Tx date 2017-05-15	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$17,710 +3,500 vol $5.06 each	23,500
Filed 2017-05-18 Tx date 2017-05-17	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$129,070 +23,700 vol $5.45 each	55,695
Filed 2017-05-17 Tx date 2017-05-15	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,098 +714 vol $4.34 each	29,169
Filed 2017-05-16 Tx date 2017-03-15	$CPH Cipher Pharmaceuticals Inc.	Bulger, Lynne Cheryl 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+1,330 vol
Filed 2017-05-16 Tx date 2017-03-15	$CPH Cipher Pharmaceuticals Inc.	Bulger, Lynne Cheryl 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,330 vol
Filed 2017-05-16 Tx date 2017-03-31	$CPH Cipher Pharmaceuticals Inc.	Bulger, Lynne Cheryl 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,330 vol	3,439
Filed 2017-05-16 Tx date 2017-03-15	$CPH Cipher Pharmaceuticals Inc.	Chypyha, Joan 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+3,092 vol
Filed 2017-05-16 Tx date 2017-03-31	$CPH Cipher Pharmaceuticals Inc.	Chypyha, Joan 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+3,092 vol	5,849
Filed 2017-05-16 Tx date 2017-03-15	$CPH Cipher Pharmaceuticals Inc.	Chypyha, Joan 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-3,092 vol
Filed 2017-05-16 Tx date 2017-03-31	$CPH Cipher Pharmaceuticals Inc.	Chypyha, Joan 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-3,092 vol	7,870
Filed 2017-05-16 Tx date 2017-05-11	$CPH Cipher Pharmaceuticals Inc.	Deboeck, Arthur Marie Joseph Ghislain 4 - Director of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report		102,800
Filed 2017-05-16 Tx date 2017-03-15	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+1,500 vol
Filed 2017-05-16 Tx date 2017-03-31	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+1,500 vol	3,169
Filed 2017-05-16 Tx date 2017-03-15	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,500 vol
Filed 2017-05-16 Tx date 2017-03-31	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,500 vol	0
Filed 2017-05-16 Tx date 2017-03-15	$CPH Cipher Pharmaceuticals Inc.	Lemieux, Stephen 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+3,582 vol
Filed 2017-05-16 Tx date 2017-03-31	$CPH Cipher Pharmaceuticals Inc.	Lemieux, Stephen 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+3,582 vol	3,582
Filed 2017-05-16 Tx date 2017-03-15	$CPH Cipher Pharmaceuticals Inc.	Lemieux, Stephen 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-3,582 vol
Filed 2017-05-16 Tx date 2017-03-15	$CPH Cipher Pharmaceuticals Inc.	Lemieux, Stephen 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-3,582 vol	7,164
Filed 2017-05-16 Tx date 2017-03-15	$CPH Cipher Pharmaceuticals Inc.	Spina, Mark 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 57 - Exercise of rights	+2,664 vol
Filed 2017-05-16 Tx date 2017-03-31	$CPH Cipher Pharmaceuticals Inc.	Weiler, Peter John 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+1,325 vol	4,244
Filed 2017-05-16 Tx date 2017-03-31	$CPH Cipher Pharmaceuticals Inc.	Spina, Mark 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 57 - Exercise of rights	+2,664 vol	7,886
Filed 2017-05-16 Tx date 2017-03-15	$CPH Cipher Pharmaceuticals Inc.	Spina, Mark 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Restricted Share Units 57 - Exercise of rights	-2,664 vol
Filed 2017-05-16 Tx date 2017-03-31	$CPH Cipher Pharmaceuticals Inc.	Spina, Mark 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Restricted Share Units 57 - Exercise of rights	-2,664 vol	4,799
Filed 2017-05-16 Tx date 2017-03-15	$CPH Cipher Pharmaceuticals Inc.	Weiler, Peter John 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+1,325 vol
Filed 2017-05-16 Tx date 2017-03-15	$CPH Cipher Pharmaceuticals Inc.	Weiler, Peter John 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,325 vol
Filed 2017-05-16 Tx date 2017-03-31	$CPH Cipher Pharmaceuticals Inc.	Weiler, Peter John 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,325 vol	3,429
Filed 2017-05-16 Tx date 2017-03-15	$CPH Cipher Pharmaceuticals Inc.	Wellner, Thomas Gordon 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+1,500 vol
Filed 2017-05-16 Tx date 2017-03-31	$CPH Cipher Pharmaceuticals Inc.	Wellner, Thomas Gordon 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+1,500 vol	16,801
Filed 2017-05-16 Tx date 2017-03-15	$CPH Cipher Pharmaceuticals Inc.	Wellner, Thomas Gordon 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,500 vol
Filed 2017-05-16 Tx date 2017-03-31	$CPH Cipher Pharmaceuticals Inc.	Wellner, Thomas Gordon 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,500 vol	0
Filed 2017-05-16 Tx date 2017-03-15	$CPH Cipher Pharmaceuticals Inc.	Wiseman, Stephen R. 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+1,500 vol
Filed 2017-05-16 Tx date 2017-03-31	$CPH Cipher Pharmaceuticals Inc.	Wiseman, Stephen R. 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+1,500 vol	15,003
Filed 2017-05-16 Tx date 2017-03-15	$CPH Cipher Pharmaceuticals Inc.	Wiseman, Stephen R. 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,500 vol
Filed 2017-05-16 Tx date 2017-03-31	$CPH Cipher Pharmaceuticals Inc.	Wiseman, Stephen R. 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,500 vol	0
Filed 2017-05-16 Tx date 2017-03-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+1,500 vol
Filed 2017-05-16 Tx date 2017-03-31	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+1,500 vol	20,518
Filed 2017-05-16 Tx date 2017-05-16	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$56,164 +10,500 vol $5.35 each	31,995
Filed 2017-05-16 Tx date 2017-03-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,500 vol
Filed 2017-05-16 Tx date 2017-03-31	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,500 vol	0
Filed 2017-05-16 Tx date 2017-03-15	$CPH Cipher Pharmaceuticals Inc.	Aigner, Stefan 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,500 vol
Filed 2017-05-16 Tx date 2017-03-31	$CPH Cipher Pharmaceuticals Inc.	Aigner, Stefan 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+1,500 vol	31,644
Filed 2017-05-16 Tx date 2017-03-15	$CPH Cipher Pharmaceuticals Inc.	Aigner, Stefan 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+1,500 vol
Filed 2017-05-16 Tx date 2017-03-31	$CPH Cipher Pharmaceuticals Inc.	Bohrer, Ralph 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+3,773 vol	4,906
Filed 2017-05-16 Tx date 2017-03-15	$CPH Cipher Pharmaceuticals Inc.	Bohrer, Ralph 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-3,773 vol
Filed 2017-05-16 Tx date 2017-03-31	$CPH Cipher Pharmaceuticals Inc.	Bohrer, Ralph 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-3,773 vol	7,545
Filed 2017-05-16 Tx date 2017-03-31	$CPH Cipher Pharmaceuticals Inc.	Bulger, Lynne Cheryl 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+1,330 vol	1,540
Filed 2017-05-16 Tx date 2017-03-15	$CPH Cipher Pharmaceuticals Inc.	Bohrer, Ralph 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+3,773 vol
Filed 2017-05-16 Tx date 2017-03-31	$CPH Cipher Pharmaceuticals Inc.	Angaritis, Linda Melanie 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,398 vol	3,614
Filed 2017-05-16 Tx date 2017-03-15	$CPH Cipher Pharmaceuticals Inc.	Angaritis, Linda Melanie 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,398 vol
Filed 2017-05-16 Tx date 2017-03-31	$CPH Cipher Pharmaceuticals Inc.	Angaritis, Linda Melanie 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+1,398 vol	2,396
Filed 2017-05-16 Tx date 2017-03-15	$CPH Cipher Pharmaceuticals Inc.	Angaritis, Linda Melanie 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+1,398 vol
Filed 2017-05-16 Tx date 2017-03-31	$CPH Cipher Pharmaceuticals Inc.	Aigner, Stefan 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,500 vol	0
Filed 2017-05-10 Tx date 2017-04-17	$CPH Cipher Pharmaceuticals Inc.	Tessarolo, Robert Dean 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report		32,900
Filed 2017-04-20 Tx date 2017-04-17	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$706.70 +191 vol $3.70 each	3,360
Filed 2017-04-20 Tx date 2017-04-17	$CPH Cipher Pharmaceuticals Inc.	Wellner, Thomas Gordon 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$2,715 +734 vol $3.70 each	17,535
Filed 2017-04-20 Tx date 2017-04-17	$CPH Cipher Pharmaceuticals Inc.	Aigner, Stefan 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,226 +872 vol $3.70 each	32,516
Filed 2017-04-20 Tx date 2017-04-17	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,614 +977 vol $3.70 each
Filed 2017-04-20 Tx date 2017-04-17	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,614 +977 vol $3.70 each	21,495
Filed 2017-04-19 Tx date 2017-04-17	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,100 +838 vol $3.70 each	28,455
Filed 2017-04-05 Tx date 2017-04-03	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,500 vol	0
Filed 2017-04-05 Tx date 2017-04-03	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+1,500 vol	27,617
Filed 2017-04-03 Tx date 2017-03-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,500 vol	0
Filed 2017-04-03 Tx date 2017-03-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+1,500 vol	20,518
Filed 2017-04-03 Tx date 2017-03-15	$CPH Cipher Pharmaceuticals Inc.	Wiseman, Stephen R. 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,500 vol	0
Filed 2017-04-03 Tx date 2017-03-15	$CPH Cipher Pharmaceuticals Inc.	Wellner, Thomas Gordon 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,500 vol	0
Filed 2017-04-03 Tx date 2017-03-15	$CPH Cipher Pharmaceuticals Inc.	Wellner, Thomas Gordon 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+1,500 vol	16,801
Filed 2017-04-03 Tx date 2017-03-15	$CPH Cipher Pharmaceuticals Inc.	Weiler, Peter John 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,325 vol	3,429
Filed 2017-04-03 Tx date 2017-03-15	$CPH Cipher Pharmaceuticals Inc.	Weiler, Peter John 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+1,325 vol	4,244
Filed 2017-04-03 Tx date 2017-03-15	$CPH Cipher Pharmaceuticals Inc.	Spina, Mark 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Restricted Share Units 57 - Exercise of rights	-2,664 vol	4,799
Filed 2017-04-03 Tx date 2017-03-15	$CPH Cipher Pharmaceuticals Inc.	Wiseman, Stephen R. 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+1,500 vol	15,003
Filed 2017-04-03 Tx date 2017-03-15	$CPH Cipher Pharmaceuticals Inc.	Spina, Mark 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 57 - Exercise of rights	+2,664 vol	7,886
Filed 2017-04-03 Tx date 2017-03-15	$CPH Cipher Pharmaceuticals Inc.	Lemieux, Stephen 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-3,582 vol	7,164
Filed 2017-04-03 Tx date 2017-03-15	$CPH Cipher Pharmaceuticals Inc.	Lemieux, Stephen 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+3,582 vol	3,582
Filed 2017-04-03 Tx date 2016-09-12	$CPH Cipher Pharmaceuticals Inc.	Lemieux, Stephen 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2017-04-03 Tx date 2017-03-15	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,500 vol	0
Filed 2017-04-03 Tx date 2017-03-15	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+1,500 vol	3,169
Filed 2017-04-03 Tx date 2017-03-15	$CPH Cipher Pharmaceuticals Inc.	Chypyha, Joan 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-3,092 vol	7,870
Filed 2017-04-03 Tx date 2017-03-15	$CPH Cipher Pharmaceuticals Inc.	Chypyha, Joan 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+3,092 vol	5,849
Filed 2017-04-03 Tx date 2017-03-15	$CPH Cipher Pharmaceuticals Inc.	Bulger, Lynne Cheryl 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,330 vol	3,439
Filed 2017-04-03 Tx date 2017-03-15	$CPH Cipher Pharmaceuticals Inc.	Bulger, Lynne Cheryl 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+1,330 vol	1,540
Filed 2017-04-03 Tx date 2017-03-15	$CPH Cipher Pharmaceuticals Inc.	Bohrer, Ralph 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-3,773 vol	7,545
Filed 2017-04-03 Tx date 2017-03-15	$CPH Cipher Pharmaceuticals Inc.	Bohrer, Ralph 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+3,773 vol	4,906
Filed 2017-04-03 Tx date 2017-03-15	$CPH Cipher Pharmaceuticals Inc.	Angaritis, Linda Melanie 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,398 vol	3,614
Filed 2017-04-03 Tx date 2017-03-15	$CPH Cipher Pharmaceuticals Inc.	Angaritis, Linda Melanie 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+1,398 vol	2,396
Filed 2017-04-03 Tx date 2017-03-15	$CPH Cipher Pharmaceuticals Inc.	Aigner, Stefan 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,500 vol	0
Filed 2017-04-03 Tx date 2017-03-15	$CPH Cipher Pharmaceuticals Inc.	Aigner, Stefan 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+1,500 vol	31,644
Filed 2017-03-18 Tx date 2017-03-15	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,100 +829 vol $3.74 each	26,117
Filed 2017-03-17 Tx date 2017-03-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,616 +967 vol $3.74 each	19,018
Filed 2017-03-17 Tx date 2017-03-15	$CPH Cipher Pharmaceuticals Inc.	Wellner, Thomas Gordon 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$2,718 +727 vol $3.74 each	15,301
Filed 2017-03-17 Tx date 2017-03-15	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$706.86 +189 vol $3.74 each	1,669
Filed 2017-03-17 Tx date 2017-03-15	$CPH Cipher Pharmaceuticals Inc.	Aigner, Stefan 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,227 +863 vol $3.74 each	30,144
Filed 2017-02-20 Tx date 2017-02-15	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,096 +776 vol $3.99 each	25,288
Filed 2017-02-17 Tx date 2017-02-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,610 +905 vol $3.99 each	18,051
Filed 2017-02-17 Tx date 2017-02-15	$CPH Cipher Pharmaceuticals Inc.	Wellner, Thomas Gordon 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$2,717 +681 vol $3.99 each	14,574
Filed 2017-02-17 Tx date 2017-02-15	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$706.23 +177 vol $3.99 each	1,480
Filed 2017-02-17 Tx date 2017-02-15	$CPH Cipher Pharmaceuticals Inc.	Aigner, Stefan 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,227 +809 vol $3.99 each	29,281
Filed 2017-01-20 Tx date 2017-01-16	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,607 +893 vol $4.04 each	17,146
Filed 2017-01-20 Tx date 2017-01-16	$CPH Cipher Pharmaceuticals Inc.	Wellner, Thomas Gordon 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$2,698 +668 vol $4.04 each	13,893
Filed 2017-01-20 Tx date 2017-01-16	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$707.00 +175 vol $4.04 each	1,303
Filed 2017-01-20 Tx date 2017-01-16	$CPH Cipher Pharmaceuticals Inc.	Aigner, Stefan 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,215 +796 vol $4.04 each	28,472
Filed 2017-01-18 Tx date 2017-01-16	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,098 +767 vol $4.04 each	24,512
Filed 2016-12-19 Tx date 2016-12-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,705 +1,074 vol $3.45 each	16,253
Filed 2016-12-19 Tx date 2016-12-15	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$703.80 +204 vol $3.45 each	1,128
Filed 2016-12-19 Tx date 2016-12-15	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,091 +896 vol $3.45 each	23,745
Filed 2016-12-19 Tx date 2016-12-15	$CPH Cipher Pharmaceuticals Inc.	Aigner, Stefan 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,432 +995 vol $3.45 each	27,676
Filed 2016-12-16 Tx date 2016-12-15	$CPH Cipher Pharmaceuticals Inc.	Wellner, Thomas Gordon 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$2,880 +835 vol $3.45 each	13,225
Filed 2016-11-18 Tx date 2016-11-15	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,100 +951 vol $3.26 each	22,849
Filed 2016-11-17 Tx date 2016-11-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,484 +1,069 vol $3.26 each	15,179
Filed 2016-11-17 Tx date 2016-11-15	$CPH Cipher Pharmaceuticals Inc.	Wellner, Thomas Gordon 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$2,878 +883 vol $3.26 each	12,390
Filed 2016-11-17 Tx date 2016-11-15	$CPH Cipher Pharmaceuticals Inc.	Spina, Mark 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$917.18 +379 vol $2.42 each	5,222
Filed 2016-11-17 Tx date 2016-11-15	$CPH Cipher Pharmaceuticals Inc.	Rosenberger, Brian 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$699.38 +289 vol $2.42 each	2,482
Filed 2016-11-17 Tx date 2016-11-15	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$775.88 +238 vol $3.26 each	924
Filed 2016-11-17 Tx date 2016-11-15	$CPH Cipher Pharmaceuticals Inc.	Aigner, Stefan 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,572 +1,096 vol $3.26 each	26,681
Filed 2016-11-17 Tx date 2016-11-15	$CPH Cipher Pharmaceuticals Inc.	O'Brien, Shawn Patrick 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$2,291 +703 vol $3.26 each	48,080
Filed 2016-10-24 Tx date 2016-10-17	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,340 +807 vol $4.14 each	14,110
Filed 2016-10-22 Tx date 2016-10-17	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$2,964 +716 vol $4.14 each	21,898
Filed 2016-10-22 Tx date 2016-10-17	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$2,965 +609 vol $4.87 each
Filed 2016-10-21 Tx date 2016-10-17	$CPH Cipher Pharmaceuticals Inc.	Wellner, Thomas Gordon 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$2,960 +715 vol $4.14 each	11,507
Filed 2016-10-21 Tx date 2016-10-17	$CPH Cipher Pharmaceuticals Inc.	Spina, Mark 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$917.28 +294 vol $3.12 each	4,843
Filed 2016-10-21 Tx date 2016-10-17	$CPH Cipher Pharmaceuticals Inc.	Rosenberger, Brian 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$698.88 +224 vol $3.12 each	2,193
Filed 2016-10-21 Tx date 2016-10-17	$CPH Cipher Pharmaceuticals Inc.	O'Brien, Shawn Patrick 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$2,289 +553 vol $4.14 each	47,377
Filed 2016-10-21 Tx date 2016-10-17	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$683.10 +165 vol $4.14 each	686
Filed 2016-10-21 Tx date 2016-10-17	$CPH Cipher Pharmaceuticals Inc.	Bohrer, Ralph 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$552.24 +177 vol $3.12 each	1,133
Filed 2016-10-21 Tx date 2016-10-17	$CPH Cipher Pharmaceuticals Inc.	Aigner, Stefan 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$894.24 +216 vol $4.14 each	25,585
Filed 2016-09-21 Tx date 2016-09-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$5,694 +1,303 vol $4.37 each	13,303
Filed 2016-09-20 Tx date 2016-09-15	$CPH Cipher Pharmaceuticals Inc.	Wellner, Thomas Gordon 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$2,945 +674 vol $4.37 each	10,792
Filed 2016-09-20 Tx date 2016-09-15	$CPH Cipher Pharmaceuticals Inc.	Spina, Mark 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$917.28 +273 vol $3.36 each	4,549
Filed 2016-09-20 Tx date 2016-09-15	$CPH Cipher Pharmaceuticals Inc.	Spina, Mark 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$917.28 +273 vol $3.36 each
Filed 2016-09-20 Tx date 2016-09-15	$CPH Cipher Pharmaceuticals Inc.	Rosenberger, Brian 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$698.88 +208 vol $3.36 each	1,969
Filed 2016-09-20 Tx date 2016-09-15	$CPH Cipher Pharmaceuticals Inc.	Rosenberger, Brian 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$698.88 +208 vol $3.36 each
Filed 2016-09-20 Tx date 2016-09-15	$CPH Cipher Pharmaceuticals Inc.	O'Brien, Shawn Patrick 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$2,289 +524 vol $4.37 each	46,824
Filed 2016-09-20 Tx date 2016-09-15	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$2,276 +521 vol $4.37 each	521
Filed 2016-09-20 Tx date 2016-09-15	$CPH Cipher Pharmaceuticals Inc.	Chypyha, Joan 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$799.71 +183 vol $4.37 each	2,757
Filed 2016-09-20 Tx date 2016-09-15	$CPH Cipher Pharmaceuticals Inc.	Bohrer, Ralph 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,105 +329 vol $3.36 each	956
Filed 2016-09-20 Tx date 2016-09-15	$CPH Cipher Pharmaceuticals Inc.	Bohrer, Ralph 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,105 +329 vol $3.36 each
Filed 2016-09-20 Tx date 2016-09-15	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$5,165 +1,182 vol $4.37 each	21,182
Filed 2016-09-20 Tx date 2016-09-15	$CPH Cipher Pharmaceuticals Inc.	Aigner, Stefan 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,447 +789 vol $4.37 each	25,369
Filed 2016-09-20 Tx date 2016-08-08	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2016-09-16 Tx date 2016-09-12	$CPH Cipher Pharmaceuticals Inc.	Lemieux, Stephen 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+10,746 vol	10,746
Filed 2016-09-16 Tx date 2016-09-12	$CPH Cipher Pharmaceuticals Inc.	Lemieux, Stephen 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2016-09-16 Tx date 2016-09-12	$CPH Cipher Pharmaceuticals Inc.	Lemieux, Stephen 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 56 - Grant of rights	+10,746 vol	10,746
Filed 2016-09-16 Tx date 2016-09-12	$CPH Cipher Pharmaceuticals Inc.	Lemieux, Stephen 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2016-09-16 Tx date 2016-09-12	$CPH Cipher Pharmaceuticals Inc.	Lemieux, Stephen 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$195,187 +37,681 vol $5.18 each	37,681
Filed 2016-09-16 Tx date 2016-09-12	$CPH Cipher Pharmaceuticals Inc.	Lemieux, Stephen 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2016-09-01 Tx date 2016-08-30	$CPH Cipher Pharmaceuticals Inc.	Mull, John 3 - 10% Security Holder of Issuer Direct Ownership	Options 51 - Exercise of options	$-200,001.40 -68,966 vol $2.90 each	26,000
Filed 2016-09-01 Tx date 2016-08-30	$CPH Cipher Pharmaceuticals Inc.	Mull, John 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$200,001 +68,966 vol $2.90 each	363,615
Filed 2016-08-18 Tx date 2016-08-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+1,500 vol	1,500
Filed 2016-08-18 Tx date 2016-08-08	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Restricted Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2016-08-18 Tx date 2016-08-15	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$123,800 +20,000 vol $6.19 each	20,000
Filed 2016-08-18 Tx date 2016-08-15	$CPH Cipher Pharmaceuticals Inc.	Spina, Mark 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$916.16 +224 vol $4.09 each	4,276
Filed 2016-08-18 Tx date 2016-08-15	$CPH Cipher Pharmaceuticals Inc.	O'Brien, Shawn Patrick 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$2,290 +429 vol $5.34 each	46,300
Filed 2016-08-18 Tx date 2016-08-15	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+1,500 vol	1,500
Filed 2016-08-18 Tx date 2016-08-08	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Restricted Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2016-08-18 Tx date 2016-08-15	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$123,800 +20,000 vol $6.19 each	20,000
Filed 2016-08-18 Tx date 2016-08-08	$CPH Cipher Pharmaceuticals Inc.	Godin, Christian 4 - Director of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2016-08-18 Tx date 2016-08-15	$CPH Cipher Pharmaceuticals Inc.	Chypyha, Joan 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$801.00 +150 vol $5.34 each	2,574
Filed 2016-08-18 Tx date 2016-08-15	$CPH Cipher Pharmaceuticals Inc.	Bohrer, Ralph 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,104 +270 vol $4.09 each	627
Filed 2016-08-18 Tx date 2016-08-15	$CPH Cipher Pharmaceuticals Inc.	Aigner, Stefan 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$8,309 +1,556 vol $5.34 each	24,580
Filed 2016-08-18 Tx date 2016-08-08	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2016-08-16 Tx date 2016-08-15	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+1,500 vol	1,500
Filed 2016-08-16 Tx date 2016-08-16	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$115,500 +20,000 vol $5.78 each	20,000
Filed 2016-08-16 Tx date 2016-08-09	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Restricted Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2016-08-16 Tx date 2016-08-15	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$123,800 +20,000 vol $6.19 each	20,000
Filed 2016-08-16 Tx date 2016-08-09	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2016-08-11 Tx date 2016-08-08	$CPH Cipher Pharmaceuticals Inc.	Wolkin, Harold Morton 4 - Director of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report		12,000
Filed 2016-08-11 Tx date 2016-08-09	$CPH Cipher Pharmaceuticals Inc.	Beaudet, Mark 4 - Director of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2016-07-19 Tx date 2016-07-15	$CPH Cipher Pharmaceuticals Inc.	Spina, Mark 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$915.40 +199 vol $4.60 each	4,052
Filed 2016-07-19 Tx date 2016-07-15	$CPH Cipher Pharmaceuticals Inc.	Rosenberger, Brian 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$699.20 +152 vol $4.60 each	1,761
Filed 2016-07-19 Tx date 2016-07-15	$CPH Cipher Pharmaceuticals Inc.	O'Brien, Shawn Patrick 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$2,292 +384 vol $5.97 each	45,871
Filed 2016-07-19 Tx date 2016-07-15	$CPH Cipher Pharmaceuticals Inc.	McDole, Gerald P. 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,599 +268 vol $5.97 each	76,611
Filed 2016-07-19 Tx date 2016-07-15	$CPH Cipher Pharmaceuticals Inc.	Claypool, William 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$9,116 +1,527 vol $5.97 each	164,048
Filed 2016-07-19 Tx date 2016-07-15	$CPH Cipher Pharmaceuticals Inc.	Chypyha, Joan 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$799.98 +134 vol $5.97 each	2,424
Filed 2016-07-19 Tx date 2016-07-15	$CPH Cipher Pharmaceuticals Inc.	Bohrer, Ralph 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,104 +240 vol $4.60 each	357
Filed 2016-07-19 Tx date 2016-07-15	$CPH Cipher Pharmaceuticals Inc.	Aigner, Stefan 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$8,829 +1,479 vol $5.97 each	23,024
Filed 2016-07-05 Tx date 2016-07-01	$CPH Cipher Pharmaceuticals Inc.	Weiler, Peter John 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-10,800 -3,750 vol $2.88 each	79,890
Filed 2016-07-05 Tx date 2016-07-01	$CPH Cipher Pharmaceuticals Inc.	Weiler, Peter John 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-3,000 -2,500 vol $1.20 each	83,640
Filed 2016-07-05 Tx date 2016-07-01	$CPH Cipher Pharmaceuticals Inc.	Weiler, Peter John 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	-3,750 vol	2,919
Filed 2016-07-05 Tx date 2016-07-01	$CPH Cipher Pharmaceuticals Inc.	Weiler, Peter John 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$10,800 +3,750 vol $2.88 each	6,669
Filed 2016-07-05 Tx date 2016-07-01	$CPH Cipher Pharmaceuticals Inc.	Weiler, Peter John 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	-2,500 vol	2,919
Filed 2016-07-05 Tx date 2016-07-01	$CPH Cipher Pharmaceuticals Inc.	Weiler, Peter John 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$3,000 +2,500 vol $1.20 each	5,419
Filed 2016-06-20 Tx date 2016-06-15	$CPH Cipher Pharmaceuticals Inc.	Wiseman, Stephen R. 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,457 +564 vol $6.13 each	13,503
Filed 2016-06-20 Tx date 2016-06-15	$CPH Cipher Pharmaceuticals Inc.	Wellner, Thomas Gordon 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,677 +763 vol $6.13 each	10,118
Filed 2016-06-20 Tx date 2016-06-15	$CPH Cipher Pharmaceuticals Inc.	Spina, Mark 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$917.62 +194 vol $4.73 each	3,853
Filed 2016-06-20 Tx date 2016-06-15	$CPH Cipher Pharmaceuticals Inc.	Rosenberger, Brian 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$700.04 +148 vol $4.73 each	1,609
Filed 2016-06-20 Tx date 2016-06-15	$CPH Cipher Pharmaceuticals Inc.	O'Brien, Shawn Patrick 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$2,292 +374 vol $6.13 each	45,487
Filed 2016-06-20 Tx date 2016-06-15	$CPH Cipher Pharmaceuticals Inc.	McDole, Gerald P. 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,002 +653 vol $6.13 each	76,343
Filed 2016-06-20 Tx date 2016-06-15	$CPH Cipher Pharmaceuticals Inc.	Claypool, William 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,462 +728 vol $6.13 each	162,521
Filed 2016-06-20 Tx date 2016-06-15	$CPH Cipher Pharmaceuticals Inc.	Chypyha, Joan 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$803.03 +131 vol $6.13 each	2,290
Filed 2016-06-20 Tx date 2016-06-15	$CPH Cipher Pharmaceuticals Inc.	Bohrer, Ralph 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$553.41 +117 vol $4.73 each	117
Filed 2016-06-20 Tx date 2016-03-10	$CPH Cipher Pharmaceuticals Inc.	Bohrer, Ralph 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2016-06-20 Tx date 2016-06-20	$CPH Cipher Pharmaceuticals Inc.	Aigner, Stefan 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$2,703 +441 vol $6.13 each	21,545
Filed 2016-06-08 Tx date 2016-06-03	$CPH Cipher Pharmaceuticals Inc.	Evans, Norman Charles 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	-10,000 vol	24,281
Filed 2016-06-08 Tx date 2016-06-06	$CPH Cipher Pharmaceuticals Inc.	Chypyha, Joan 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	-454 vol	2,159
Filed 2016-05-17 Tx date 2016-05-16	$CPH Cipher Pharmaceuticals Inc.	Wiseman, Stephen R. 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,796 +584 vol $6.50 each	12,939
Filed 2016-05-17 Tx date 2016-05-16	$CPH Cipher Pharmaceuticals Inc.	Wellner, Thomas Gordon 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$2,866 +441 vol $6.50 each	9,355
Filed 2016-05-17 Tx date 2016-05-16	$CPH Cipher Pharmaceuticals Inc.	Spina, Mark 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,640 +917 vol $5.06 each	3,659
Filed 2016-05-17 Tx date 2016-05-16	$CPH Cipher Pharmaceuticals Inc.	Rosenberger, Brian 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,361 +862 vol $5.06 each	1,461
Filed 2016-05-17 Tx date 2016-05-16	$CPH Cipher Pharmaceuticals Inc.	O'Brien, Shawn Patrick 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$2,294 +353 vol $6.50 each	45,113
Filed 2016-05-17 Tx date 2016-05-16	$CPH Cipher Pharmaceuticals Inc.	McDole, Gerald P. 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,599 +246 vol $6.50 each	75,690
Filed 2016-05-17 Tx date 2016-05-16	$CPH Cipher Pharmaceuticals Inc.	Claypool, William 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,458 +532 vol $6.50 each	161,793
Filed 2016-05-17 Tx date 2016-05-16	$CPH Cipher Pharmaceuticals Inc.	Chypyha, Joan 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$799.50 +123 vol $6.50 each	2,613
Filed 2016-05-17 Tx date 2016-05-16	$CPH Cipher Pharmaceuticals Inc.	Aigner, Stefan 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$2,892 +445 vol $6.50 each	21,104
Filed 2016-05-13 Tx date 2016-05-09	$CPH Cipher Pharmaceuticals Inc.	Tannenbaum, Renate 4 - Director of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+1,500 vol	1,500
Filed 2016-05-13 Tx date 2016-05-05	$CPH Cipher Pharmaceuticals Inc.	Tannenbaum, Renate 4 - Director of Issuer Direct Ownership	Restricted Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2016-05-13 Tx date 2016-05-09	$CPH Cipher Pharmaceuticals Inc.	Tannenbaum, Renate 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$151,800 +20,000 vol $7.59 each	20,000
Filed 2016-05-13 Tx date 2016-05-05	$CPH Cipher Pharmaceuticals Inc.	Tannenbaum, Renate 4 - Director of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2016-05-13 Tx date 2016-05-09	$CPH Cipher Pharmaceuticals Inc.	Crane, Rosemary 4 - Director of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+1,500 vol	1,500
Filed 2016-05-13 Tx date 2016-05-05	$CPH Cipher Pharmaceuticals Inc.	Crane, Rosemary 4 - Director of Issuer Direct Ownership	Restricted Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2016-05-13 Tx date 2016-05-09	$CPH Cipher Pharmaceuticals Inc.	Crane, Rosemary 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$151,800 +20,000 vol $7.59 each	20,000
Filed 2016-05-13 Tx date 2016-05-05	$CPH Cipher Pharmaceuticals Inc.	Crane, Rosemary 4 - Director of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2016-04-20 Tx date 2016-04-15	$CPH Cipher Pharmaceuticals Inc.	Wiseman, Stephen R. 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,205 +477 vol $6.72 each	12,355
Filed 2016-04-20 Tx date 2016-04-15	$CPH Cipher Pharmaceuticals Inc.	Wellner, Thomas Gordon 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,955 +291 vol $6.72 each	8,914
Filed 2016-04-20 Tx date 2016-04-15	$CPH Cipher Pharmaceuticals Inc.	Spina, Mark 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$915.20 +176 vol $5.20 each	2,742
Filed 2016-04-20 Tx date 2016-04-15	$CPH Cipher Pharmaceuticals Inc.	Rosenberger, Brian 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,024 +197 vol $5.20 each	599
Filed 2016-04-20 Tx date 2016-04-15	$CPH Cipher Pharmaceuticals Inc.	O'Brien, Shawn Patrick 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$2,291 +341 vol $6.72 each	44,760
Filed 2016-04-20 Tx date 2016-04-15	$CPH Cipher Pharmaceuticals Inc.	McDole, Gerald P. 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,599 +238 vol $6.72 each	75,444
Filed 2016-04-20 Tx date 2016-04-15	$CPH Cipher Pharmaceuticals Inc.	Claypool, William 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,171 +472 vol $6.72 each	161,261
Filed 2016-04-20 Tx date 2016-04-15	$CPH Cipher Pharmaceuticals Inc.	Chypyha, Joan 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$799.68 +119 vol $6.72 each	2,490
Filed 2016-04-20 Tx date 2016-04-15	$CPH Cipher Pharmaceuticals Inc.	Bohrer, Ralph 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+11,318 vol	11,318
Filed 2016-04-20 Tx date 2016-03-10	$CPH Cipher Pharmaceuticals Inc.	Bohrer, Ralph 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2016-04-20 Tx date 2016-04-15	$CPH Cipher Pharmaceuticals Inc.	Bohrer, Ralph 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 56 - Grant of rights	+11,318 vol	11,318
Filed 2016-04-20 Tx date 2016-03-10	$CPH Cipher Pharmaceuticals Inc.	Bohrer, Ralph 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2016-04-20 Tx date 2016-04-15	$CPH Cipher Pharmaceuticals Inc.	Bohrer, Ralph 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$157,193 +33,805 vol $4.65 each	33,805
Filed 2016-04-20 Tx date 2016-04-15	$CPH Cipher Pharmaceuticals Inc.	Aigner, Stefan 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$2,714 +404 vol $6.72 each	20,659
Filed 2016-04-20 Tx date 2016-03-10	$CPH Cipher Pharmaceuticals Inc.	Bohrer, Ralph 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2016-03-31 Tx date 2016-03-30	$CPH Cipher Pharmaceuticals Inc.	Mull, John 3 - 10% Security Holder of Issuer Holder: 1207407 Ontario Limited (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$6,050 +1,000 vol $6.05 each	9,386,150
Filed 2016-03-30 Tx date 2016-03-29	$CPH Cipher Pharmaceuticals Inc.	Mull, John 3 - 10% Security Holder of Issuer Holder: 1207407 Ontario Limited (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$8,470 +1,400 vol $6.05 each	9,385,150
Filed 2016-03-29 Tx date 2016-03-28	$CPH Cipher Pharmaceuticals Inc.	Mull, John 3 - 10% Security Holder of Issuer Holder: 1207407 Ontario Limited (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$57,475 +9,500 vol $6.05 each	9,383,750
Filed 2016-03-28 Tx date 2016-03-24	$CPH Cipher Pharmaceuticals Inc.	Mull, John 3 - 10% Security Holder of Issuer Holder: 1207407 Ontario Limited (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$30,855 +5,100 vol $6.05 each	9,374,250
Filed 2016-03-27 Tx date 2016-03-22	$CPH Cipher Pharmaceuticals Inc.	Wellner, Thomas Gordon 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	-692 vol	8,623
Filed 2016-03-27 Tx date 2016-03-22	$CPH Cipher Pharmaceuticals Inc.	Weiler, Peter John 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	-181 vol	2,919
Filed 2016-03-27 Tx date 2016-03-22	$CPH Cipher Pharmaceuticals Inc.	Rosenberger, Brian 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	-175 vol	402
Filed 2016-03-27 Tx date 2016-03-22	$CPH Cipher Pharmaceuticals Inc.	Bulger, Lynne Cheryl 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	-181 vol	210
Filed 2016-03-27 Tx date 2016-03-22	$CPH Cipher Pharmaceuticals Inc.	Blythe, Louis 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	-185 vol	215
Filed 2016-03-27 Tx date 2016-03-22	$CPH Cipher Pharmaceuticals Inc.	Angaritis, Linda Melanie 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	-190 vol	998
Filed 2016-03-27 Tx date 2016-03-22	$CPH Cipher Pharmaceuticals Inc.	Aigner, Stefan 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	-692 vol	20,255
Filed 2016-03-27 Tx date 2016-03-22	$CPH Cipher Pharmaceuticals Inc.	Claypool, William 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	-692 vol	160,789
Filed 2016-03-27 Tx date 2016-03-22	$CPH Cipher Pharmaceuticals Inc.	Chypyha, Joan 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	-389 vol	2,371
Filed 2016-03-24 Tx date 2016-03-23	$CPH Cipher Pharmaceuticals Inc.	Mull, John 3 - 10% Security Holder of Issuer Holder: 1207407 Ontario Limited (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$51,425 +8,500 vol $6.05 each	9,369,150
Filed 2016-03-21 Tx date 2016-03-18	$CPH Cipher Pharmaceuticals Inc.	Mull, John 3 - 10% Security Holder of Issuer Holder: 1207407 Ontario Limited (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$66,550 +11,000 vol $6.05 each	9,360,650
Filed 2016-03-20 Tx date 2016-03-15	$CPH Cipher Pharmaceuticals Inc.	Wiseman, Stephen R. 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,500 vol	1,500
Filed 2016-03-20 Tx date 2016-03-15	$CPH Cipher Pharmaceuticals Inc.	Wiseman, Stephen R. 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$18,957 +3,550 vol $5.34 each	10,378
Filed 2016-03-20 Tx date 2016-03-15	$CPH Cipher Pharmaceuticals Inc.	Wellner, Thomas Gordon 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,500 vol	1,500
Filed 2016-03-20 Tx date 2016-03-15	$CPH Cipher Pharmaceuticals Inc.	Wellner, Thomas Gordon 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+1,500 vol	9,315
Filed 2016-03-20 Tx date 2016-03-15	$CPH Cipher Pharmaceuticals Inc.	Wellner, Thomas Gordon 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$14,802 +2,772 vol $5.34 each	7,815
Filed 2016-03-20 Tx date 2016-03-15	$CPH Cipher Pharmaceuticals Inc.	Weiler, Peter John 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-391 vol	4,754
Filed 2016-03-20 Tx date 2016-03-15	$CPH Cipher Pharmaceuticals Inc.	Weiler, Peter John 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+391 vol	3,100
Filed 2016-03-20 Tx date 2016-03-16	$CPH Cipher Pharmaceuticals Inc.	Spina, Mark 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Restricted Share Units 57 - Exercise of rights	-529 vol	7,463
Filed 2016-03-20 Tx date 2016-03-15	$CPH Cipher Pharmaceuticals Inc.	Spina, Mark 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 57 - Exercise of rights	+529 vol	2,566
Filed 2016-03-20 Tx date 2016-03-15	$CPH Cipher Pharmaceuticals Inc.	Spina, Mark 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$915.75 +225 vol $4.07 each	2,037
Filed 2016-03-20 Tx date 2016-03-15	$CPH Cipher Pharmaceuticals Inc.	Rosenberger, Brian 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-577 vol	11,642
Filed 2016-03-20 Tx date 2016-03-15	$CPH Cipher Pharmaceuticals Inc.	Rosenberger, Brian 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+577 vol	577
Filed 2016-03-20 Tx date 2015-05-14	$CPH Cipher Pharmaceuticals Inc.	Rosenberger, Brian 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2016-03-20 Tx date 2016-03-15	$CPH Cipher Pharmaceuticals Inc.	O'Brien, Shawn Patrick 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-2,294 vol	31,158
Filed 2016-03-20 Tx date 2016-03-15	$CPH Cipher Pharmaceuticals Inc.	O'Brien, Shawn Patrick 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+2,294 vol	44,419
Filed 2016-03-20 Tx date 2016-03-15	$CPH Cipher Pharmaceuticals Inc.	O'Brien, Shawn Patrick 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$2,627 +492 vol $5.34 each	42,125
Filed 2016-03-20 Tx date 2016-03-15	$CPH Cipher Pharmaceuticals Inc.	McDole, Gerald P. 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,500 vol	1,500
Filed 2016-03-20 Tx date 2016-03-15	$CPH Cipher Pharmaceuticals Inc.	McDole, Gerald P. 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+1,500 vol	75,206
Filed 2016-03-20 Tx date 2016-03-15	$CPH Cipher Pharmaceuticals Inc.	McDole, Gerald P. 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,198 +599 vol $5.34 each	73,706
Filed 2016-03-20 Tx date 2016-03-15	$CPH Cipher Pharmaceuticals Inc.	Evans, Norman Charles 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-859 vol	11,148
Filed 2016-03-20 Tx date 2016-03-15	$CPH Cipher Pharmaceuticals Inc.	Evans, Norman Charles 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+859 vol	34,281
Filed 2016-03-20 Tx date 2016-03-15	$CPH Cipher Pharmaceuticals Inc.	Claypool, William 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,500 vol	1,500
Filed 2016-03-20 Tx date 2016-03-15	$CPH Cipher Pharmaceuticals Inc.	Claypool, William 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+1,500 vol	161,481
Filed 2016-03-20 Tx date 2016-03-15	$CPH Cipher Pharmaceuticals Inc.	Claypool, William 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$12,762 +2,390 vol $5.34 each	159,981
Filed 2016-03-20 Tx date 2016-03-15	$CPH Cipher Pharmaceuticals Inc.	Chypyha, Joan 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-843 vol	10,962
Filed 2016-03-20 Tx date 2016-03-15	$CPH Cipher Pharmaceuticals Inc.	Chypyha, Joan 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$801.00 +150 vol $5.34 each	1,917
Filed 2016-03-20 Tx date 2016-03-15	$CPH Cipher Pharmaceuticals Inc.	Bulger, Lynne Cheryl 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-391 vol	4,769
Filed 2016-03-20 Tx date 2016-03-15	$CPH Cipher Pharmaceuticals Inc.	Bulger, Lynne Cheryl 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+391 vol	391
Filed 2016-03-20 Tx date 2015-01-19	$CPH Cipher Pharmaceuticals Inc.	Bulger, Lynne Cheryl 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2016-03-20 Tx date 2016-03-15	$CPH Cipher Pharmaceuticals Inc.	Blythe, Louis 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-400 vol	4,849
Filed 2016-03-20 Tx date 2016-03-15	$CPH Cipher Pharmaceuticals Inc.	Angaritis, Linda Melanie 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-410 vol	5,012
Filed 2016-03-20 Tx date 2016-03-15	$CPH Cipher Pharmaceuticals Inc.	Angaritis, Linda Melanie 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+410 vol	1,188
Filed 2016-03-20 Tx date 2016-03-15	$CPH Cipher Pharmaceuticals Inc.	Aigner, Stefan 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,500 vol	1,500
Filed 2016-03-20 Tx date 2016-03-15	$CPH Cipher Pharmaceuticals Inc.	Aigner, Stefan 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+1,500 vol	20,947
Filed 2016-03-20 Tx date 2016-03-15	$CPH Cipher Pharmaceuticals Inc.	Aigner, Stefan 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$10,856 +2,033 vol $5.34 each	19,447
Filed 2016-03-20 Tx date 2015-05-14	$CPH Cipher Pharmaceuticals Inc.	Blythe, Louis 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2016-03-20 Tx date 2016-03-15	$CPH Cipher Pharmaceuticals Inc.	Wiseman, Stephen R. 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+1,500 vol	11,878
Filed 2016-03-20 Tx date 2016-03-15	$CPH Cipher Pharmaceuticals Inc.	Chypyha, Joan 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+843 vol	2,760
Filed 2016-03-20 Tx date 2016-03-15	$CPH Cipher Pharmaceuticals Inc.	Blythe, Louis 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+400 vol	400
Filed 2016-03-16 Tx date 2016-03-15	$CPH Cipher Pharmaceuticals Inc.	Mull, John 3 - 10% Security Holder of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-1,500 vol	1,500
Filed 2016-03-16 Tx date 2016-03-15	$CPH Cipher Pharmaceuticals Inc.	Mull, John 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+1,500 vol	294,649
Filed 2016-03-14 Tx date 2016-03-11	$CPH Cipher Pharmaceuticals Inc.	Mull, John 3 - 10% Security Holder of Issuer Holder: 1207407 Ontario Limited (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$3,025 +500 vol $6.05 each	9,349,650
Filed 2016-03-09 Tx date 2016-03-08	$CPH Cipher Pharmaceuticals Inc.	Mull, John 3 - 10% Security Holder of Issuer Direct Ownership	Options 51 - Exercise of options	$-82,400 -20,000 vol $4.12 each	94,966
Filed 2016-03-09 Tx date 2016-03-08	$CPH Cipher Pharmaceuticals Inc.	Mull, John 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$82,400 +20,000 vol $4.12 each	293,149
Filed 2016-03-04 Tx date 2016-03-03	$CPH Cipher Pharmaceuticals Inc.	McDole, Gerald P. 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-82,400 -20,000 vol $4.12 each	26,000
Filed 2016-03-04 Tx date 2016-03-03	$CPH Cipher Pharmaceuticals Inc.	McDole, Gerald P. 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$82,400 +20,000 vol $4.12 each	73,107
Filed 2016-03-02 Tx date 2016-02-26	$CPH Cipher Pharmaceuticals Inc.	Wiseman, Stephen R. 4 - Director of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+1,500 vol	3,000
Filed 2016-03-02 Tx date 2016-02-26	$CPH Cipher Pharmaceuticals Inc.	Wiseman, Stephen R. 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$33,950 +5,000 vol $6.79 each	20,750
Filed 2016-03-02 Tx date 2016-02-26	$CPH Cipher Pharmaceuticals Inc.	Wellner, Thomas Gordon 4 - Director of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+1,500 vol	3,000
Filed 2016-03-02 Tx date 2016-02-26	$CPH Cipher Pharmaceuticals Inc.	Wellner, Thomas Gordon 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$33,950 +5,000 vol $6.79 each	28,500
Filed 2016-03-02 Tx date 2016-02-26	$CPH Cipher Pharmaceuticals Inc.	Weiler, Peter John 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+3,973 vol	5,145
Filed 2016-03-02 Tx date 2016-02-26	$CPH Cipher Pharmaceuticals Inc.	Weiler, Peter John 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 56 - Grant of rights	+3,973 vol	5,145
Filed 2016-03-02 Tx date 2016-02-26	$CPH Cipher Pharmaceuticals Inc.	Weiler, Peter John 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$73,943 +10,890 vol $6.79 each	86,140
Filed 2016-03-02 Tx date 2016-02-26	$CPH Cipher Pharmaceuticals Inc.	Spina, Mark 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Restricted Share Units 50 - Grant of options	+6,406 vol	7,992
Filed 2016-03-02 Tx date 2016-02-26	$CPH Cipher Pharmaceuticals Inc.	Spina, Mark 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Performance Share Units 56 - Grant of rights	+6,406 vol	7,992
Filed 2016-03-02 Tx date 2016-02-26	$CPH Cipher Pharmaceuticals Inc.	Spina, Mark 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Options 50 - Grant of options	$86,314 +17,508 vol $4.93 each	32,674
Filed 2016-03-02 Tx date 2016-02-26	$CPH Cipher Pharmaceuticals Inc.	Rosenberger, Brian 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+10,489 vol	12,219
Filed 2016-03-02 Tx date 2016-02-26	$CPH Cipher Pharmaceuticals Inc.	Rosenberger, Brian 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 56 - Grant of rights	+10,489 vol	12,219
Filed 2016-03-02 Tx date 2016-02-26	$CPH Cipher Pharmaceuticals Inc.	Rosenberger, Brian 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$141,323 +28,666 vol $4.93 each	62,666
Filed 2016-03-02 Tx date 2016-02-26	$CPH Cipher Pharmaceuticals Inc.	O'Brien, Shawn Patrick 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+26,569 vol	33,452
Filed 2016-03-02 Tx date 2016-02-26	$CPH Cipher Pharmaceuticals Inc.	O'Brien, Shawn Patrick 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 56 - Grant of rights	+26,569 vol	33,452
Filed 2016-03-02 Tx date 2016-02-26	$CPH Cipher Pharmaceuticals Inc.	O'Brien, Shawn Patrick 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$494,502 +72,828 vol $6.79 each	382,828
Filed 2016-03-02 Tx date 2016-02-26	$CPH Cipher Pharmaceuticals Inc.	McDole, Gerald P. 4 - Director of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+1,500 vol	3,000
Filed 2016-03-02 Tx date 2016-02-26	$CPH Cipher Pharmaceuticals Inc.	McDole, Gerald P. 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$33,950 +5,000 vol $6.79 each	46,000
Filed 2016-03-02 Tx date 2016-02-26	$CPH Cipher Pharmaceuticals Inc.	Evans, Norman Charles 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+9,430 vol	12,007
Filed 2016-03-02 Tx date 2016-02-26	$CPH Cipher Pharmaceuticals Inc.	Evans, Norman Charles 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 56 - Grant of rights	+9,430 vol	12,007
Filed 2016-03-02 Tx date 2016-02-26	$CPH Cipher Pharmaceuticals Inc.	Evans, Norman Charles 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$175,501 +25,847 vol $6.79 each	298,347
Filed 2016-03-02 Tx date 2016-02-26	$CPH Cipher Pharmaceuticals Inc.	Claypool, William 4 - Director of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+1,500 vol	3,000
Filed 2016-03-02 Tx date 2016-02-26	$CPH Cipher Pharmaceuticals Inc.	Claypool, William 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$33,950 +5,000 vol $6.79 each	22,500
Filed 2016-03-02 Tx date 2016-02-26	$CPH Cipher Pharmaceuticals Inc.	Chypyha, Joan 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+9,275 vol	11,805
Filed 2016-03-02 Tx date 2016-02-26	$CPH Cipher Pharmaceuticals Inc.	Chypyha, Joan 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 56 - Grant of rights	+9,275 vol	11,805
Filed 2016-03-02 Tx date 2016-02-26	$CPH Cipher Pharmaceuticals Inc.	Chypyha, Joan 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$172,628 +25,424 vol $6.79 each	152,924
Filed 2016-03-02 Tx date 2016-02-26	$CPH Cipher Pharmaceuticals Inc.	Bulger, Lynne Cheryl 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+3,988 vol	5,160
Filed 2016-03-02 Tx date 2016-02-26	$CPH Cipher Pharmaceuticals Inc.	Bulger, Lynne Cheryl 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 56 - Grant of rights	+3,988 vol	5,160
Filed 2016-03-02 Tx date 2016-02-26	$CPH Cipher Pharmaceuticals Inc.	Bulger, Lynne Cheryl 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$74,228 +10,932 vol $6.79 each	33,432
Filed 2016-03-02 Tx date 2016-02-26	$CPH Cipher Pharmaceuticals Inc.	Blythe, Louis 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+4,048 vol	5,249
Filed 2016-03-02 Tx date 2016-02-26	$CPH Cipher Pharmaceuticals Inc.	Blythe, Louis 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 56 - Grant of rights	+4,048 vol	5,249
Filed 2016-03-02 Tx date 2016-02-26	$CPH Cipher Pharmaceuticals Inc.	Blythe, Louis 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$75,348 +11,097 vol $6.79 each	35,097
Filed 2016-03-02 Tx date 2016-02-26	$CPH Cipher Pharmaceuticals Inc.	Angaritis, Linda Melanie 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+4,192 vol	5,422
Filed 2016-03-02 Tx date 2016-02-26	$CPH Cipher Pharmaceuticals Inc.	Angaritis, Linda Melanie 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 56 - Grant of rights	+4,192 vol	5,422
Filed 2016-03-02 Tx date 2016-02-26	$CPH Cipher Pharmaceuticals Inc.	Angaritis, Linda Melanie 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$78,017 +11,490 vol $6.79 each	89,990
Filed 2016-03-02 Tx date 2016-02-26	$CPH Cipher Pharmaceuticals Inc.	Aigner, Stefan 4 - Director of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+1,500 vol	3,000
Filed 2016-03-02 Tx date 2016-02-26	$CPH Cipher Pharmaceuticals Inc.	Aigner, Stefan 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$33,950 +5,000 vol $6.79 each	46,000
Filed 2016-02-23 Tx date 2016-02-18	$CPH Cipher Pharmaceuticals Inc.	Wiseman, Stephen R. 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,002 +687 vol $4.37 each	6,828
Filed 2016-02-23 Tx date 2016-02-18	$CPH Cipher Pharmaceuticals Inc.	Wellner, Thomas Gordon 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$2,001 +458 vol $4.37 each	5,043
Filed 2016-02-23 Tx date 2016-02-18	$CPH Cipher Pharmaceuticals Inc.	Spina, Mark 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$915.20 +286 vol $3.20 each	1,812
Filed 2016-02-23 Tx date 2016-02-18	$CPH Cipher Pharmaceuticals Inc.	O'Brien, Shawn Patrick 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,957 +448 vol $4.37 each	41,633
Filed 2016-02-23 Tx date 2016-02-18	$CPH Cipher Pharmaceuticals Inc.	McDole, Gerald P. 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,599 +366 vol $4.37 each	53,107
Filed 2016-02-23 Tx date 2016-02-18	$CPH Cipher Pharmaceuticals Inc.	Claypool, William 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$2,600 +595 vol $4.37 each	157,591
Filed 2016-02-23 Tx date 2016-02-18	$CPH Cipher Pharmaceuticals Inc.	Chypyha, Joan 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$799.71 +183 vol $4.37 each	1,767
Filed 2016-02-23 Tx date 2016-02-18	$CPH Cipher Pharmaceuticals Inc.	Aigner, Stefan 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$2,001 +458 vol $4.37 each	17,414
Filed 2016-01-21 Tx date 2016-01-18	$CPH Cipher Pharmaceuticals Inc.	Wiseman, Stephen R. 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$6,048 +1,186 vol $5.10 each	6,141
Filed 2016-01-21 Tx date 2016-01-18	$CPH Cipher Pharmaceuticals Inc.	Wellner, Thomas Gordon 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,416 +670 vol $5.10 each	4,585
Filed 2016-01-21 Tx date 2016-01-18	$CPH Cipher Pharmaceuticals Inc.	Spina, Mark 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$918.39 +253 vol $3.63 each	1,526
Filed 2016-01-21 Tx date 2016-01-18	$CPH Cipher Pharmaceuticals Inc.	O'Brien, Shawn Patrick 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$902.70 +177 vol $5.10 each	41,185
Filed 2016-01-21 Tx date 2016-01-18	$CPH Cipher Pharmaceuticals Inc.	McDole, Gerald P. 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$800.70 +157 vol $5.10 each	52,741
Filed 2016-01-21 Tx date 2016-01-18	$CPH Cipher Pharmaceuticals Inc.	Claypool, William 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$397.80 +78 vol $5.10 each	156,996
Filed 2016-01-21 Tx date 2016-01-18	$CPH Cipher Pharmaceuticals Inc.	Aigner, Stefan 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,866 +366 vol $5.10 each	16,956
Filed 2016-01-21 Tx date 2016-01-18	$CPH Cipher Pharmaceuticals Inc.	Chypyha, Joan 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$397.80 +78 vol $5.10 each	1,584
Filed 2015-12-17 Tx date 2015-12-15	$CPH Cipher Pharmaceuticals Inc.	Wiseman, Stephen R. 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$2,788 +601 vol $4.64 each	4,955
Filed 2015-12-17 Tx date 2015-12-15	$CPH Cipher Pharmaceuticals Inc.	Wellner, Thomas Gordon 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,605 +346 vol $4.64 each	3,915
Filed 2015-12-17 Tx date 2015-12-15	$CPH Cipher Pharmaceuticals Inc.	Weiler, Peter John 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$162.40 +35 vol $4.64 each	2,709
Filed 2015-12-17 Tx date 2015-12-14	$CPH Cipher Pharmaceuticals Inc.	Weiler, Peter John 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	-3,200 vol	2,674
Filed 2015-12-17 Tx date 2015-12-15	$CPH Cipher Pharmaceuticals Inc.	Spina, Mark 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,069 +328 vol $3.26 each	1,273
Filed 2015-12-17 Tx date 2015-12-15	$CPH Cipher Pharmaceuticals Inc.	Spina, Mark 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,146 +1,272 vol $3.26 each
Filed 2015-12-17 Tx date 2015-12-15	$CPH Cipher Pharmaceuticals Inc.	Pecora, Joseph 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,146 +1,272 vol $3.26 each	5,550
Filed 2015-12-17 Tx date 2015-12-15	$CPH Cipher Pharmaceuticals Inc.	O'Brien, Shawn Patrick 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,814 +391 vol $4.64 each	41,008
Filed 2015-12-17 Tx date 2015-12-15	$CPH Cipher Pharmaceuticals Inc.	McDole, Gerald P. 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,600 +345 vol $4.64 each	52,584
Filed 2015-12-17 Tx date 2015-12-15	$CPH Cipher Pharmaceuticals Inc.	Claypool, William 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$2,398 +517 vol $4.64 each	156,918
Filed 2015-12-17 Tx date 2015-12-15	$CPH Cipher Pharmaceuticals Inc.	Chypyha, Joan 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$812.00 +175 vol $4.64 each	1,506
Filed 2015-12-17 Tx date 2015-12-15	$CPH Cipher Pharmaceuticals Inc.	Aigner, Stefan 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,197 +258 vol $4.64 each	16,590
Filed 2015-11-20 Tx date 2015-11-16	$CPH Cipher Pharmaceuticals Inc.	Wiseman, Stephen R. 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,983 +775 vol $5.14 each	4,354
Filed 2015-11-20 Tx date 2015-11-16	$CPH Cipher Pharmaceuticals Inc.	Wellner, Thomas Gordon 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,245 +826 vol $5.14 each	3,569
Filed 2015-11-20 Tx date 2015-11-16	$CPH Cipher Pharmaceuticals Inc.	Weiler, Peter John 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$2,307 +449 vol $5.14 each	5,874
Filed 2015-11-20 Tx date 2015-11-16	$CPH Cipher Pharmaceuticals Inc.	Spina, Mark 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$778.14 +198 vol $3.93 each	945
Filed 2015-11-20 Tx date 2015-11-16	$CPH Cipher Pharmaceuticals Inc.	Pecora, Joseph 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,000 +1,018 vol $3.93 each	4,278
Filed 2015-11-20 Tx date 2015-11-16	$CPH Cipher Pharmaceuticals Inc.	O'Brien, Shawn Patrick 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$2,713 +528 vol $5.14 each	40,617
Filed 2015-11-20 Tx date 2015-11-16	$CPH Cipher Pharmaceuticals Inc.	McDole, Gerald P. 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$2,400 +467 vol $5.14 each	52,239
Filed 2015-11-20 Tx date 2015-11-16	$CPH Cipher Pharmaceuticals Inc.	Claypool, William 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,343 +845 vol $5.14 each	156,401
Filed 2015-11-20 Tx date 2015-11-16	$CPH Cipher Pharmaceuticals Inc.	Chypyha, Joan 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,197 +233 vol $5.14 each	1,331
Filed 2015-11-20 Tx date 2015-11-16	$CPH Cipher Pharmaceuticals Inc.	Aigner, Stefan 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,140 +611 vol $5.14 each	16,332
Filed 2015-10-18 Tx date 2015-10-15	$CPH Cipher Pharmaceuticals Inc.	Wiseman, Stephen R. 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,788 +801 vol $4.73 each	3,579
Filed 2015-10-18 Tx date 2015-10-15	$CPH Cipher Pharmaceuticals Inc.	Wellner, Thomas Gordon 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,395 +295 vol $4.73 each	2,743
Filed 2015-10-18 Tx date 2015-10-15	$CPH Cipher Pharmaceuticals Inc.	Weiler, Peter John 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$2,298 +486 vol $4.73 each	5,425
Filed 2015-10-18 Tx date 2015-10-15	$CPH Cipher Pharmaceuticals Inc.	Spina, Mark 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$917.87 +263 vol $3.49 each	747
Filed 2015-10-18 Tx date 2015-10-15	$CPH Cipher Pharmaceuticals Inc.	Pecora, Joseph 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,999 +1,146 vol $3.49 each	3,260
Filed 2015-10-18 Tx date 2015-10-15	$CPH Cipher Pharmaceuticals Inc.	O'Brien, Shawn Patrick 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$2,700 +571 vol $4.73 each	40,089
Filed 2015-10-18 Tx date 2015-10-15	$CPH Cipher Pharmaceuticals Inc.	McDole, Gerald P. 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$2,388 +505 vol $4.73 each	51,772
Filed 2015-10-18 Tx date 2015-10-15	$CPH Cipher Pharmaceuticals Inc.	Evans, Norman Charles 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$198.66 +42 vol $4.73 each	33,422
Filed 2015-10-18 Tx date 2015-10-15	$CPH Cipher Pharmaceuticals Inc.	Claypool, William 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$2,890 +611 vol $4.73 each	155,556
Filed 2015-10-18 Tx date 2015-10-15	$CPH Cipher Pharmaceuticals Inc.	Chypyha, Joan 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,196 +253 vol $4.73 each	1,098
Filed 2015-10-18 Tx date 2015-10-15	$CPH Cipher Pharmaceuticals Inc.	Aigner, Stefan 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$2,890 +611 vol $4.73 each	15,721
Filed 2015-09-18 Tx date 2015-09-15	$CPH Cipher Pharmaceuticals Inc.	Wiseman, Stephen R. 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$2,601 +473 vol $5.50 each	2,778
Filed 2015-09-18 Tx date 2015-09-15	$CPH Cipher Pharmaceuticals Inc.	Wieler, Peter John 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,540 +280 vol $5.50 each	4,939
Filed 2015-09-18 Tx date 2015-09-15	$CPH Cipher Pharmaceuticals Inc.	Wellner, Thomas Gordon 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,001 +182 vol $5.50 each	2,448
Filed 2015-09-18 Tx date 2015-09-15	$CPH Cipher Pharmaceuticals Inc.	Spina, Mark 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$915.60 +218 vol $4.20 each	484
Filed 2015-09-18 Tx date 2015-09-15	$CPH Cipher Pharmaceuticals Inc.	Pecora, Joseph 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,998 +952 vol $4.20 each	2,114
Filed 2015-09-18 Tx date 2015-09-15	$CPH Cipher Pharmaceuticals Inc.	O'Brien, Shawn Patrick 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$11,808 +2,147 vol $5.50 each	39,518
Filed 2015-09-18 Tx date 2015-09-15	$CPH Cipher Pharmaceuticals Inc.	McDole, Gerald P. 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,600 +291 vol $5.50 each	51,267
Filed 2015-09-18 Tx date 2015-09-15	$CPH Cipher Pharmaceuticals Inc.	Evans, Norman Charles 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$19,998 +3,636 vol $5.50 each	33,380
Filed 2015-09-18 Tx date 2015-09-15	$CPH Cipher Pharmaceuticals Inc.	Chypyha, Joan 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$797.50 +145 vol $5.50 each	845
Filed 2015-09-18 Tx date 2015-09-15	$CPH Cipher Pharmaceuticals Inc.	Aigner, Stefan 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$2,002 +364 vol $5.50 each	15,110
Filed 2015-09-18 Tx date 2015-09-15	$CPH Cipher Pharmaceuticals Inc.	Claypool, William 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$2,002 +364 vol $5.50 each	154,945
Filed 2015-09-15 Tx date 2015-09-10	$CPH Cipher Pharmaceuticals Inc.	Claypool, William 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-11,000 -20,000 vol $0.55 each	17,500
Filed 2015-09-15 Tx date 2015-09-10	$CPH Cipher Pharmaceuticals Inc.	Claypool, William 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$11,000 +20,000 vol $0.55 each	154,581
Filed 2015-09-09 Tx date 2015-09-04	$CPH Cipher Pharmaceuticals Inc.	Wiseman, Stephen R. 4 - Director of Issuer Holder: Wiseman MCS Inc. (Control or Direction)	Common Shares 97 - Other	+25,000 vol	25,000
Filed 2015-09-09 Tx date 2005-08-03	$CPH Cipher Pharmaceuticals Inc.	Wiseman, Stephen R. 4 - Director of Issuer Holder: Wiseman MCS Inc. (Control or Direction)	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2015-09-09 Tx date 2015-09-04	$CPH Cipher Pharmaceuticals Inc.	Wiseman, Stephen R. 4 - Director of Issuer Holder: The Stephen and Elaine Wiseman Family Trust (Control or Direction)	Common Shares 97 - Other	-25,000 vol	0
Filed 2015-08-21 Tx date 2015-08-17	$CPH Cipher Pharmaceuticals Inc.	Wiseman, Stephen R. 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$2,602 +304 vol $8.56 each	2,305
Filed 2015-08-21 Tx date 2015-08-17	$CPH Cipher Pharmaceuticals Inc.	Wieler, Peter John 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,540 +180 vol $8.56 each	4,659
Filed 2015-08-21 Tx date 2015-08-17	$CPH Cipher Pharmaceuticals Inc.	Wellner, Thomas Gordon 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,001 +117 vol $8.56 each	2,266
Filed 2015-08-21 Tx date 2015-08-17	$CPH Cipher Pharmaceuticals Inc.	Spina, Mark 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$916.37 +133 vol $6.89 each	266
Filed 2015-08-21 Tx date 2015-08-17	$CPH Cipher Pharmaceuticals Inc.	Pecora, Joseph 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,003 +581 vol $6.89 each	1,162
Filed 2015-08-21 Tx date 2015-08-17	$CPH Cipher Pharmaceuticals Inc.	O'Brien, Shawn Patrick 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,806 +211 vol $8.56 each	37,371
Filed 2015-08-21 Tx date 2015-08-17	$CPH Cipher Pharmaceuticals Inc.	McDole, Gerald P. 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,600 +187 vol $8.56 each	50,976
Filed 2015-08-21 Tx date 2015-08-17	$CPH Cipher Pharmaceuticals Inc.	Claypool, William 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$2,003 +234 vol $8.56 each	134,581
Filed 2015-08-21 Tx date 2015-08-17	$CPH Cipher Pharmaceuticals Inc.	Chypyha, Joan 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$796.08 +93 vol $8.56 each	700
Filed 2015-08-21 Tx date 2015-08-17	$CPH Cipher Pharmaceuticals Inc.	Aigner, Stefan 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$2,003 +234 vol $8.56 each	14,746
Filed 2015-07-20 Tx date 2015-07-15	$CPH Cipher Pharmaceuticals Inc.	Wiseman, Stephen R. 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,582 +408 vol $8.78 each	2,001
Filed 2015-07-20 Tx date 2015-07-15	$CPH Cipher Pharmaceuticals Inc.	Wieler, Peter John 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,536 +175 vol $8.78 each	4,479
Filed 2015-07-20 Tx date 2015-07-15	$CPH Cipher Pharmaceuticals Inc.	Wellner, Thomas Gordon 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,441 +392 vol $8.78 each	2,149
Filed 2015-07-20 Tx date 2015-07-15	$CPH Cipher Pharmaceuticals Inc.	Spina, Mark 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$916.37 +133 vol $6.89 each	133
Filed 2015-07-20 Tx date 2015-04-13	$CPH Cipher Pharmaceuticals Inc.	Spina, Mark 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2015-07-20 Tx date 2015-07-15	$CPH Cipher Pharmaceuticals Inc.	Pecora, Joseph 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$4,003 +581 vol $6.89 each	581
Filed 2015-07-20 Tx date 2015-04-13	$CPH Cipher Pharmaceuticals Inc.	Pecora, Joseph 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2015-07-20 Tx date 2015-07-15	$CPH Cipher Pharmaceuticals Inc.	O'Brien, Shawn Patrick 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,808 +206 vol $8.78 each	37,160
Filed 2015-07-20 Tx date 2015-07-15	$CPH Cipher Pharmaceuticals Inc.	Chypyha, Joan 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$798.98 +91 vol $8.78 each	607
Filed 2015-07-20 Tx date 2015-07-20	$CPH Cipher Pharmaceuticals Inc.	Aigner, Stefan 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$2,748 +313 vol $8.78 each	14,512
Filed 2015-07-20 Tx date 2015-07-15	$CPH Cipher Pharmaceuticals Inc.	McDole, Gerald P. 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,597 +182 vol $8.78 each	50,789
Filed 2015-07-20 Tx date 2015-07-15	$CPH Cipher Pharmaceuticals Inc.	Claypool, William 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,415 +389 vol $8.78 each	134,347
Filed 2015-07-03 Tx date 2015-06-29	$CPH Cipher Pharmaceuticals Inc.	O'Brien, Shawn Patrick 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$71,448 +8,203 vol $8.71 each	36,954
Filed 2015-07-03 Tx date 2015-06-30	$CPH Cipher Pharmaceuticals Inc.	Aigner, Stefan 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-85,040 -8,000 vol $10.63 each	14,199
Filed 2015-07-02 Tx date 2015-06-25	$CPH Cipher Pharmaceuticals Inc.	Mull, John 3 - 10% Security Holder of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+1,500 vol	1,500
Filed 2015-07-02 Tx date 2004-02-23	$CPH Cipher Pharmaceuticals Inc.	Mull, John 3 - 10% Security Holder of Issuer Direct Ownership	Restricted Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2015-06-30 Tx date 2005-08-03	$CPH Cipher Pharmaceuticals Inc.	Wiseman, Stephen R. 4 - Director of Issuer Direct Ownership	Restricted Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2015-06-30 Tx date 2015-06-25	$CPH Cipher Pharmaceuticals Inc.	Wieler, Peter John 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+1,172 vol	1,172
Filed 2015-06-30 Tx date 2015-01-19	$CPH Cipher Pharmaceuticals Inc.	Wieler, Peter John 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2015-06-30 Tx date 2015-06-25	$CPH Cipher Pharmaceuticals Inc.	Wieler, Peter John 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 56 - Grant of rights	+1,172 vol	1,172
Filed 2015-06-30 Tx date 2015-06-25	$CPH Cipher Pharmaceuticals Inc.	Wiseman, Stephen R. 4 - Director of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+1,500 vol	1,500
Filed 2015-06-30 Tx date 2014-03-12	$CPH Cipher Pharmaceuticals Inc.	Wellner, Thomas Gordon 4 - Director of Issuer Direct Ownership	Restricted Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2015-06-30 Tx date 2015-06-25	$CPH Cipher Pharmaceuticals Inc.	Spina, Mark 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Restricted Share Units 56 - Grant of rights	+1,586 vol	1,586
Filed 2015-06-30 Tx date 2015-04-13	$CPH Cipher Pharmaceuticals Inc.	Spina, Mark 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Restricted Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2015-06-30 Tx date 2015-06-25	$CPH Cipher Pharmaceuticals Inc.	Spina, Mark 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Performance Share Units 56 - Grant of rights	+1,586 vol	1,586
Filed 2015-06-30 Tx date 2015-01-19	$CPH Cipher Pharmaceuticals Inc.	Wieler, Peter John 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2015-06-30 Tx date 2015-06-25	$CPH Cipher Pharmaceuticals Inc.	Wellner, Thomas Gordon 4 - Director of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+1,500 vol	1,500
Filed 2015-06-30 Tx date 2015-04-13	$CPH Cipher Pharmaceuticals Inc.	Spina, Mark 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Performance Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2015-06-30 Tx date 2015-06-25	$CPH Cipher Pharmaceuticals Inc.	Spina, Mark 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Options 50 - Grant of options	$131,489 +15,166 vol $8.67 each	15,166
Filed 2015-06-30 Tx date 2015-04-13	$CPH Cipher Pharmaceuticals Inc.	Spina, Mark 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2015-06-30 Tx date 2015-06-25	$CPH Cipher Pharmaceuticals Inc.	Rosenberger, Brian 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+1,730 vol	1,730
Filed 2015-06-30 Tx date 2015-05-14	$CPH Cipher Pharmaceuticals Inc.	Rosenberger, Brian 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2015-06-30 Tx date 2015-06-25	$CPH Cipher Pharmaceuticals Inc.	Rosenberger, Brian 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 56 - Grant of rights	+1,730 vol	1,730
Filed 2015-06-30 Tx date 2015-05-14	$CPH Cipher Pharmaceuticals Inc.	Rosenberger, Brian 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2015-06-30 Tx date 2015-06-25	$CPH Cipher Pharmaceuticals Inc.	Pecora, Joseph 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Restricted Share Units 56 - Grant of rights	+2,768 vol	2,768
Filed 2015-06-30 Tx date 2015-04-13	$CPH Cipher Pharmaceuticals Inc.	Pecora, Joseph 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Restricted Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2015-06-30 Tx date 2015-06-25	$CPH Cipher Pharmaceuticals Inc.	Pecora, Joseph 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Performance Share Units 56 - Grant of rights	+2,768 vol	2,768
Filed 2015-06-30 Tx date 2015-04-13	$CPH Cipher Pharmaceuticals Inc.	Pecora, Joseph 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Performance Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2015-06-30 Tx date 2015-06-25	$CPH Cipher Pharmaceuticals Inc.	Pecora, Joseph 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Options 50 - Grant of options	$229,512 +26,472 vol $8.67 each	26,472
Filed 2015-06-30 Tx date 2015-04-13	$CPH Cipher Pharmaceuticals Inc.	Pecora, Joseph 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2015-06-30 Tx date 2015-06-25	$CPH Cipher Pharmaceuticals Inc.	O'Brien, Shawn Patrick 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	$73,441 +6,883 vol $10.67 each	6,883
Filed 2015-06-30 Tx date 2014-06-30	$CPH Cipher Pharmaceuticals Inc.	O'Brien, Shawn Patrick 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2015-06-30 Tx date 2015-06-25	$CPH Cipher Pharmaceuticals Inc.	O'Brien, Shawn Patrick 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 56 - Grant of rights	+6,883 vol	6,883
Filed 2015-06-30 Tx date 2014-06-30	$CPH Cipher Pharmaceuticals Inc.	O'Brien, Shawn Patrick 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2015-06-30 Tx date 2015-06-25	$CPH Cipher Pharmaceuticals Inc.	McDole, Gerald P. 4 - Director of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+1,500 vol	1,500
Filed 2015-06-30 Tx date 2004-02-23	$CPH Cipher Pharmaceuticals Inc.	McDole, Gerald P. 4 - Director of Issuer Direct Ownership	Restricted Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2015-06-30 Tx date 2015-06-25	$CPH Cipher Pharmaceuticals Inc.	Evans, Norman Charles 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+2,577 vol	2,577
Filed 2015-06-30 Tx date 2007-03-09	$CPH Cipher Pharmaceuticals Inc.	Evans, Norman Charles 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2015-06-30 Tx date 2015-06-25	$CPH Cipher Pharmaceuticals Inc.	Evans, Norman Charles 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 56 - Grant of rights	+2,577 vol	2,577
Filed 2015-06-30 Tx date 2007-03-09	$CPH Cipher Pharmaceuticals Inc.	Evans, Norman Charles 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2015-06-30 Tx date 2015-06-25	$CPH Cipher Pharmaceuticals Inc.	Claypool, William 4 - Director of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+1,500 vol	1,500
Filed 2015-06-30 Tx date 2009-11-03	$CPH Cipher Pharmaceuticals Inc.	Claypool, William 4 - Director of Issuer Direct Ownership	Restricted Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2015-06-30 Tx date 2015-06-25	$CPH Cipher Pharmaceuticals Inc.	Chypyha, Joan 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+2,530 vol	2,530
Filed 2015-06-30 Tx date 2013-03-04	$CPH Cipher Pharmaceuticals Inc.	Chypyha, Joan 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2015-06-30 Tx date 2015-06-25	$CPH Cipher Pharmaceuticals Inc.	Chypyha, Joan 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 56 - Grant of rights	+2,530 vol	2,530
Filed 2015-06-30 Tx date 2013-03-04	$CPH Cipher Pharmaceuticals Inc.	Chypyha, Joan 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2015-06-30 Tx date 2015-06-25	$CPH Cipher Pharmaceuticals Inc.	Bulger, Lynne Cheryl 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+1,172 vol	1,172
Filed 2015-06-30 Tx date 2015-01-19	$CPH Cipher Pharmaceuticals Inc.	Bulger, Lynne Cheryl 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2015-06-30 Tx date 2015-06-25	$CPH Cipher Pharmaceuticals Inc.	Bulger, Lynne Cheryl 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 56 - Grant of rights	+1,172 vol	1,172
Filed 2015-06-30 Tx date 2015-01-19	$CPH Cipher Pharmaceuticals Inc.	Bulger, Lynne Cheryl 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2015-06-30 Tx date 2015-06-25	$CPH Cipher Pharmaceuticals Inc.	Blythe, Louis 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+1,201 vol	1,201
Filed 2015-06-30 Tx date 2015-05-14	$CPH Cipher Pharmaceuticals Inc.	Blythe, Louis 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2015-06-30 Tx date 2015-06-25	$CPH Cipher Pharmaceuticals Inc.	Blythe, Louis 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 56 - Grant of rights	+1,201 vol	1,201
Filed 2015-06-30 Tx date 2015-05-14	$CPH Cipher Pharmaceuticals Inc.	Blythe, Louis 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2015-06-30 Tx date 2015-06-25	$CPH Cipher Pharmaceuticals Inc.	Angaritis, Linda Melanie 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+1,230 vol	1,230
Filed 2015-06-30 Tx date 2015-01-19	$CPH Cipher Pharmaceuticals Inc.	Angaritis, Linda Melanie 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2015-06-30 Tx date 2015-06-25	$CPH Cipher Pharmaceuticals Inc.	Angaritis, Linda Melanie 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 56 - Grant of rights	+1,230 vol	1,230
Filed 2015-06-30 Tx date 2015-01-19	$CPH Cipher Pharmaceuticals Inc.	Angaritis, Linda Melanie 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2015-06-30 Tx date 2015-06-25	$CPH Cipher Pharmaceuticals Inc.	Alba, Jonathan David 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Restricted Share Units 56 - Grant of rights	+1,847 vol	1,847
Filed 2015-06-30 Tx date 2015-04-13	$CPH Cipher Pharmaceuticals Inc.	Alba, Jonathan David 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Restricted Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2015-06-30 Tx date 2015-06-25	$CPH Cipher Pharmaceuticals Inc.	Alba, Jonathan David 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Performance Share Units 56 - Grant of rights	+1,847 vol	1,847
Filed 2015-06-30 Tx date 2015-04-13	$CPH Cipher Pharmaceuticals Inc.	Alba, Jonathan David 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Performance Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2015-06-30 Tx date 2015-06-25	$CPH Cipher Pharmaceuticals Inc.	Alba, Jonathan David 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Options 50 - Grant of options	$153,146 +17,664 vol $8.67 each	17,664
Filed 2015-06-30 Tx date 2015-04-13	$CPH Cipher Pharmaceuticals Inc.	Alba, Jonathan David 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2015-06-30 Tx date 2015-06-25	$CPH Cipher Pharmaceuticals Inc.	Aigner, Stefan 4 - Director of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+1,500 vol	1,500
Filed 2015-06-30 Tx date 2007-12-06	$CPH Cipher Pharmaceuticals Inc.	Aigner, Stefan 4 - Director of Issuer Direct Ownership	Restricted Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2015-06-30 Tx date 2015-06-29	$CPH Cipher Pharmaceuticals Inc.	Aigner, Stefan 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-106,700 -10,000 vol $10.67 each	22,199
Filed 2015-06-24 Tx date 2015-06-19	$CPH Cipher Pharmaceuticals Inc.	Aigner, Stefan 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-127,848 -12,000 vol $10.65 each	32,199
Filed 2015-06-02 Tx date 2015-04-17	$CPH Cipher Pharmaceuticals Inc.	Claypool, William 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+3,500 vol	37,500
Filed 2015-06-02 Tx date 2015-02-24	$CPH Cipher Pharmaceuticals Inc.	Claypool, William 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+3,500 vol
Filed 2015-05-29 Tx date 2015-05-27	$CPH Cipher Pharmaceuticals Inc.	O'Brien, Shawn Patrick 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$22,302 +1,800 vol $12.39 each	28,751
Filed 2015-05-29 Tx date 2015-05-26	$CPH Cipher Pharmaceuticals Inc.	O'Brien, Shawn Patrick 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$101,598 +8,200 vol $12.39 each	26,951
Filed 2015-05-28 Tx date 2015-05-15	$CPH Cipher Pharmaceuticals Inc.	Rosenberger, Brian 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$342,040 +34,000 vol $10.06 each	34,000
Filed 2015-05-28 Tx date 2015-05-14	$CPH Cipher Pharmaceuticals Inc.	Rosenberger, Brian 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2015-05-27 Tx date 2015-05-25	$CPH Cipher Pharmaceuticals Inc.	Wiseman, Stephen R. 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$3,598 +346 vol $10.40 each	1,593
Filed 2015-05-27 Tx date 2015-05-25	$CPH Cipher Pharmaceuticals Inc.	Wieler, Peter John 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$2,308 +222 vol $10.40 each	4,304
Filed 2015-05-27 Tx date 2015-05-25	$CPH Cipher Pharmaceuticals Inc.	Wellner, Thomas Gordon 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,196 +115 vol $10.40 each	1,757
Filed 2015-05-27 Tx date 2015-05-25	$CPH Cipher Pharmaceuticals Inc.	O'Brien, Shawn Patrick 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$2,714 +261 vol $10.40 each	18,751
Filed 2015-05-27 Tx date 2015-05-25	$CPH Cipher Pharmaceuticals Inc.	McDole, Gerald P. 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$2,402 +231 vol $10.40 each	50,607
Filed 2015-05-27 Tx date 2015-05-22	$CPH Cipher Pharmaceuticals Inc.	Evans, Norman Charles 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-18,000 -15,000 vol $1.20 each	272,500
Filed 2015-05-27 Tx date 2015-05-22	$CPH Cipher Pharmaceuticals Inc.	Evans, Norman Charles 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-23,200 -20,000 vol $1.16 each	287,500
Filed 2015-05-27 Tx date 2015-05-22	$CPH Cipher Pharmaceuticals Inc.	Evans, Norman Charles 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-16,000 -10,000 vol $1.60 each	307,500
Filed 2015-05-27 Tx date 2015-05-25	$CPH Cipher Pharmaceuticals Inc.	Evans, Norman Charles 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,196 +115 vol $10.40 each	29,744
Filed 2015-05-27 Tx date 2015-05-22	$CPH Cipher Pharmaceuticals Inc.	Evans, Norman Charles 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	-45,000 vol	29,629
Filed 2015-05-27 Tx date 2015-05-22	$CPH Cipher Pharmaceuticals Inc.	Evans, Norman Charles 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$18,000 +15,000 vol $1.20 each	74,629
Filed 2015-05-27 Tx date 2015-05-22	$CPH Cipher Pharmaceuticals Inc.	Evans, Norman Charles 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$23,200 +20,000 vol $1.16 each	59,629
Filed 2015-05-27 Tx date 2015-05-22	$CPH Cipher Pharmaceuticals Inc.	Evans, Norman Charles 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$16,000 +10,000 vol $1.60 each	39,629
Filed 2015-05-27 Tx date 2015-05-22	$CPH Cipher Pharmaceuticals Inc.	Evans, Norman Charles 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	-5,000 vol	29,629
Filed 2015-05-27 Tx date 2015-05-25	$CPH Cipher Pharmaceuticals Inc.	Claypool, William 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$2,704 +260 vol $10.40 each	133,958
Filed 2015-05-27 Tx date 2015-05-25	$CPH Cipher Pharmaceuticals Inc.	Chypyha, Joan 5 - Senior Officer of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$1,196 +115 vol $10.40 each	516
Filed 2015-05-27 Tx date 2015-05-15	$CPH Cipher Pharmaceuticals Inc.	Blythe, Louis 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$288,720 +24,000 vol $12.03 each	24,000
Filed 2015-05-27 Tx date 2015-05-14	$CPH Cipher Pharmaceuticals Inc.	Blythe, Louis 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2015-05-27 Tx date 2015-05-25	$CPH Cipher Pharmaceuticals Inc.	Aigner, Stefan 4 - Director of Issuer Direct Ownership	Common Shares 30 - Acquisition or disposition under a purchase/ownership plan	$2,704 +260 vol $10.40 each	44,199